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COPP: The first point to consider in homeostasis of calcium is the 
remarkable constancy of the level of calcium in plasma and body fluids 
in the normal animal. This is illustrated in figure 1, which shows the 
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FIGURE I .  
adult male. 
diurnal fluctuations of plasma calcium and phosphorus in a normal 
adult male subject in Shaughnessy Hospital, Vancouver, British Co- 
lumbia. Although the calcium level is very constant, there is consid- 
erable fluctuation in the plasma phosphate and in the urinary excretion 
of both elements. The same constancy in plasma calcium has been 
observed in normal dogs and rats. 
The main factors affecting plasma calcium are shown in figure 2 
(ref. 11). These factors include absorption of calcium from food 
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from ref. 1 1 ; reprinted by permission of the publisher.] 
Factors involved in control of the plasma calcium level. [Adapted 
and excretion of calcium in feces, urine, and sweat. However, the 
most important single factor is the tremendous reservoir of calcium 
in bone, which may amount to over 1 kilogram in a 70-kilogram man. 
We believe that the tiny crystals of bone salt act like the particles of 
an ion exchange resin, providing a labile exchangeable calcium pool 
of 3 to 6 grams in a normal adult man, and that this acts as a buffer to 
help prevent wide fluctuations in the level of plasma calcium, How- 
ever, in the long run, the balance between calcium accretion in bone 
formation and calcium release from bone during osteolysis is more 
important. I believe that these two processes are affected by the con- 
centrations of calcium and phosphate in blood, by the presence or 
absence of vitamin D, and particularly by the activity of two potent 
hormones -the parathyroid hormone, produced by the parathyroids, 
and calcitonin, or thyrocalcitonin, from the thyroid. Diet is also a 
factor. Figure 3 shows that normal rats fed a phosphate-deficient 
diet are hypercalcemic in the morning. 
RAISZ: Why do you think they are hypercalcemic in the morning? 
COPP: Rats feed during the night, and increased metabolic activity 
requires phosphate for phosphorylative reactions. This increased 
activity, particularly on a phosphate-deficient diet, lowers the plasma 
phosphate, and in my opinion this result interferes with bone deposition 
of calcium. At the same time, calcium is absorbed from the gut at night. 
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FIGURE 3. Changes in plasma calcium and phosphate in 5-week-old rats re- 
stricted to a diet low in calcium Bnd phosphate. Note the marked changes in 
plasma phosphate associated with nocturnal feeding habits. 
FREMONT-SMITH: Is most of the food intake at night? 
COPP: Yes. Rats eat almost entirely at night. If you turn off the 
lights in the daytime you may be able to persuade them to eat something, 
but rats are rather shy and carry on most of their activities at night. 
HOWELL: Do you have similar data for man? 
COPP: No; we do not. It is almost impossible to get a phosphate- 
free diet that is acceptable to man. 
NICHOLS: It is an important point then that this cannot be observed 
in man except to the degree that one can restrict the availability of 
dietary phosphate. 
COPP: You may get some response in a hyperparathyroid patient 
with hypercalcemia when phosphate restriction may increase the plasma 
calcium level. 
Our rats had essentially no phosphate in their diet and were growing 
rapidly, so that the phosphate required for soft tissues was obtained at 
the expense of the skeleton. We have shown that parathyroidec- 
tomized rats fed a low phosphate diet will develop hypercalcemia, even' 
when the diet is also low in calcium. 
PRITCHARD: I would like to ask a question in reference to what you 
have said. In reading about calcium and phosphate concentrations, 
one finds that one level always seems to go up as the other concentra- 
tion goes down. Do calcium and phosphate always move in opposite 
directions? 
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COPP: Sometimes changes in calcium and phosphate move in the 
same direction, sometimes opposite. It depends on many factors. 
PRITCHARD: I thought you were assuming that because the phos- 
phate was down the,calcium must go up. 
COPP: No. With these phosphate-deficient diets we find that as 
blood phosphate falls, blood calcium rises. This is true particularly 
in the parathyroidectomized rat. 
PRITCHARD: Is this a matter of mass action, or is it something 
biologic? 
COPP: I think there may be two factors. Low concentrations of 
phosphate may affect the rate of bone deposition of calcium. At very 
low blood phosphate concentrations, there may be little or no formation 
of new bone mineral; high concentrations may have the opposite effect. 
This would account for a reciprocal relationship between calcium and 
phosphate and would account for some of the observations of Fuller 
Albright. I feel that an effect on bone formation would be critical. 
Phosphate deficiency also affects the response of the animal to para- 
thyroid hormone and thyrocalcitonin. There will also be an effect on 
calcium absorption from the gut; this absorption is enhanced at low 
phosphate concentrations and reduced when the dietary phosphate is 
high. We observed that phosphate deficiency with low plasma phos- 
phate also results in tremendous urinary excretion of calcium (ref. 12). 
PRITCHARD: It is doubtless not a simple relationship. 
COPP: That is true. 
BAUER: In general, Dr. Copp, do your data show that your animals 
had enough vitamin D? 
COPP: Yes. The animals received adequate but not excessive vitamin 
D. The diet contained 20 U.S.P. units vitamin D per gram, which is 
7 times the recommended minimum. 
I will assume that we all agree that plasma calcium is controlled with 
remarkable precision and efficiency in the normal animal. Figure 4 
(ref. 13)  shows that this precise control is lost when the thyroid and 
parathyroid glands are removed. In 200 normal dogs, the fasting 
plasma calcium concentration falls within a rather narrow distribution 
curve. In the thyroparathyroidectomized dogs, there is a great vari- 
ability in the fasting plasma calcium concentration. This impairment 
in homeostatic control is demonstrated even more dramatically when 
the system is stressed by infusion of calcium or of the calcium chelating 
agent, EDTA (ethylenediaminetetraacetate). Sanderson et al. (ref. 14) 
found, in normal dogs (fig. 5 ) ,  that the plasma calcium returned to 
the original concentration a few hours after it had been raised by in- 
fusion of calcium or lowered by injection of EDTA. This precise 
control was lost after thyroparathyroidectomy, as shown in figure 6, 
and the blood calcium was still not back to the original concentration 
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FIGURE 4. Distribution of fasting plasma calcium concentrations in normal and thyro- 
parathyroidectomized adult dogs. [Adapted from ref. 13; reprinted by permission of the 
publisher.] 
24 hours later. It is apparent that the glands were required for rapid, 
efficient homeostatic control of both hypocalcemia and hypercalcemia. 
FREMONT-SMITH: There is a tendency to return toward normal 
values that starts quite promptly, is there not? 
COPP: Yes. This tendency to return toward normal was observed 
even in the thyroparathyroidectomized dogs, but it occurred much 
more slowly. 
FREMONT-SMITH: The reason I raise this point is because L. J. 
Henderson found, in his work on the constancy of the pH in the blood 
(ref. 15), that as one homeostatic factor after another was removed, 
secondary factors came in. I wonder whether Lhere were not secondary 
factors to manage the calcium concentration in this situation. 
COPP: Yes, I think so. There is a gradual recovery to the initial 
concentration within 24 to 48 'hours following induced hypocalcemia 
or hypercalcemia. I believe that this is a result of a secondary and 
less sensitive control. If we assume that the rate of calcium deposition 
in bone is a function of the ionic calcium concentration, hypercalcemia 
should increase calcium deposition in bone and lower plasma calcium; 
yet hypocalcemia will have the opposite effect. 
FREMONT-SMITH: Is the bone reservoir the main secondary factor? 
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FIGURE 5. Changes in plasma calcium during and after intravenous infusion 
of calcium (15 mg/kg) or the EDTA equivalent of calcium (5 mg/kg) for 1 hour 
in normal adult dogs. [Replotted from data of Sanderson et al., ref. 14.1 
COPP: Yes, and the relative balance between accretion and resorption. 
PECK: What is the effect of age on this process? 
COPP: Recovery is much faster in young animals than in old ones, 
not only with regard to the hormone response in intact animals, but also 
with regard to recovery in parathyroidectomized dogs. 
HOWELL: In the dog, is there not a problem of accessory gland re- 
maining in the mediastinum? 
COPP: We do not worry about this. Our animals behave as if they 
were parathyroidectomized, and in over 200 operations we have seen 
no evidence of functional accessory glands. 
TALMAGE: I would like to stress briefly the homeostatic control of 
calcium in the absence of the parathyroid gland. Even in the absence 
of the gland, plasma calcium concentrations tend to equilibrate, al- 
though at a lower concentration. However, because the equilibration 
process under these conditions is based primarily on physicochemical 
properties, the rate of equilibration is much slower. On a calcium-free 
diet, a basic level will be maintained and will be affected only by the 
low rate of calcium reabsorption by the kidney tubule. If an animal 
is maintained on a high calcium diet, the basic level may never be 
reached; the calcium concentration in the blood may be extremely 
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FIGURE 6.  Changes in plasma calcium during and after intravenous infusion of 
calcium (15 mg/kg) or the EDTA equivalent of calcium (5 mg/kg) into thyro- 
parathyroidectomized dogs. Note the impaired homeostatic control of both 
hypocalcemia and hypercalcemia. [Replotted from data of Sanderson et al., 
ref. 14.1 
variable and may even reach a concentration higher than that seen in 
the normal animal. The important point is that even in a parathyroidec- 
tomized animal the bone can provide calcium to the fluid compartments. 
COPP: This is one of the secondary factors that Dr. Fremont-Smith 
mentioned. 
WALSER: I would like to raise a slightly semantic objection which I 
raised some years ago. EDTA does not induce hypocalcemia; it 
induces hypercalcemia. The same is true of citrate or protein. You 
can raise plasma calcium by infusing either. I do not think you would 
use the word hypocalcemia for those situations and I do not see why 
we should for this situation. 
COPP: Your semantic point is well taken, but it does not alter the fact 
that EDTA produces physiologic hypocalcemia. 
WALSER: I think the assumption that physiologic calcium has been 
measured by what you have illustrated is a little risky. 
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COPP: I do not agree. This is evident from the response of the para- 
thyroids to EDTA-induced hypocalcemia. 
RAISZ: I would like to carry this further. A question pertinent to 
your study is whether there is any effect of EDTA separate from the 
,chelating of calcium. I agree that ionized calcium effects probably 
determine the responses in the whole animal where a modest amount 
of EDTA is being infused. When larger amounts of EDTA are given, 
however, we are no longer studying the effects on calcium but study- 
ing the effects of EDTA on tissue which can be substantial. EDTA 
has toxic effects on transport systems of cell membranes in many 
tissues that we have studied; these effects are entirely separate from 
the calcium effect. 
EDTA complexes a number of important 
trace metals and prolonged administration may have deleterious effects. 
However, I do not think that these effects are important if you infuse 
EDTA for only a few hours, as has often been done in human subjects. 
But, for example, after 2 to 3 days of EDTA infusion in sheep, the ani- 
mals often sickened and died. 
TALMAGE: One must keep in mind that the same type of response 
may be obtained without EDTA. This response can be found in any 
method by which plasma calcium is lowered dramatically. The cal- 
cium invariably returns rapidly to the predetermined concentration. 
NICHOLS: I do not think that EDTA’s effect on tissues should be 
discussed as necessarily being unrelated to calcium. Indeed, it is 
probable that the transport effects you observe are actually effects 
on the membrane structure, which in turn are probably related to the 
binding of calcium into these membranes. For example, one can 
abolish sodium and potassium transport in red cells with EDTA and 
restore it again by adding enough calcium to saturate the EDTA present 
and leave a small excess (G. Nichols, unpublished observations). 
RAISZ: But you can show that EDTA is bound to the membrane 
itself; that is, that even after all the calcium has been chelated there is 
still further binding of EDTA. Another point is that such ions as citrate, 
oxalate, or phosphate can be used to lower the calcium. We have had 
better results with these than with EDTA in the whole animal (ref. 16). 
NICHOLS: I would like to comment about man and EDTA infusions. 
One can obtain data in man, which are not dissimilar from yours, Dr. 
Copp, as probably many here have done. Our own experience with 
man has been a fair copy of what you have shown in animals, with the ex- 
ception that the duration of the whole phenomenon seems to be quite 
a bit longer. This is probably partly because we have infused for 4 
hours rather than for 1 hour (with the specific intent of being sure the 
parathyroids have been shut off), but we do not get calcium returning 
to normal following EDTA infusion for quite a few hours. Inciden- 
tally, the same is true for calcium infusions in man. 
COPP: I agree completely. 
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COPP: This probably reflects differences in the metabolic activity of 
the skeleton. 
ARNAUD: Dr. Nichols, are these data from a parathyroidectomized 
subject? 
NICHOLS: No. The data were from normal people. If you have 
a parathyroidectomized subject the response is even slower. Another 
interesting phenomenon is that in carcinoma of the parathyroid, or 
occasionally in adenoma with hyperparathyroidism, serum calcium 
concentrations may go up and stay up after calcium infusions. We 
have seen them still elevated 4 days later. 
Figure 7 shows the 
plasma calcium curve for a normal adult human male subject following 
a 1-hour calcium infusion. Recovery is somewhat slower than in the 
dog, but after 24 hours plasma calcium concentration is almost back to 
normal. Figure 8 shows the curve following a similar infusion in a 
thyroparathyroidectomized adult human male subject of similar age, 
and confirms Dr. Nichols’ observation that the calcium concentration 
in plasma remains elevated. 
NICHOLS: Dr. Talmage points out that this is probably related to 
the fact than an adult man does not use his gut as a calcium pool for 
COPP: The next two figures illustrate this point. 
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FIGURE 7. Changes in plasma calcium during and after intravenous infusion of 
calcium (10 mdkg) in a normal adult man. [From the Clinical Investigation 
Unit, Shaughnessy Hospital, Vancouver, B.C.] 
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FIGURE 8. Changes in plasma calcium during and after intravenous infusion 
of calcium (10 mg/kg) into an adult man who had been thyroparathyroidecto- 
mized a number of years earlier. Note the impaired control of hypercalcemia. 
[From data supplied by Dr. H. W. McIntosh, Department of Medicine, Univer- 
sity of British Columbia, Vancouver, B.C.] 
ready availability but instead depends upon his bone which is kept in 
a state of availability by the presence of parathyroid hormone. 
HOLTZER: How did this patient have a normal calcium concentration 
in the beginning? Was he on vitamin D therapy? 
COPP: He was maintained on a high calcium diet of 0.2 milligram 
thyroxine and 50 000 XU vitamin D daily. 
The second item to be considered in our discussion should be the 
function of bone in calcium homeostasis. Over 99 percent of the cal- 
cium in the body is located in the skeleton, and this amount may be over 
1 kilogram calcium in a 70-kilogram man, as mentioned previously. 
It is also probable that the regulating hormones from the thyroid and 
the parathyroid glands exert their effect primarily by action on bone. 
Considering the nature of bone mineral, we find the most significant 
physical feature is the extremely minute dimensions of the crystals, 
which provide an enormous area for surface exchange. In many re- 
spects these crystals are comparable to the resin particles of an ion 
exchange column and act in much the same way to release or to adsorb 
ions present in the surrounding body fluids. Figure 9 shows a stylized 
model of such a crystal and indicates the way in which calcium on its 
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FIGURE 9. Diagrammatic model of exchange between calcium in blood and calcium on 
the surface of the crystals of bone mineral. 
surface could exchange with calcium in plasma. In my opinion, this 
surface exchange is a physicochemical process that is independent of 
the energy-dependent and biologically active processes of accretion 
and bone resorption. 
Dr. Robinson, will you comment on this and on the ultrastructure 
of bone where these processes probably take place? 
ROBINSON: The crystal in figure 9 is one which I think is perfectly 
valid. With better resolution we still observe that those bone crystals 
large enough for their habit to be observed are tablet shaped. Accord- 
ing to X-ray and spot electron diffraction patterns their fundamental 
atomic lattice pattern is that of hydroxyapatite with some variability 
of their simple surface composition. These small crystals are probably 
flattened plaques, which increases the surface-to-mass ratio; these 
crystals are supposed to occupy, as we conceive the process in min- 
eralization, water space that originally existed in the matrix shortly 
after this matrix was formed by the cell. 
As the crystals occupy this space and the water is displaced to give 
them room, less and less water becomes available for ion exchange in 
areas around the surface of these crystals. Finally, the situation 
is such that in a fully mineralized bone matrix, the crystals on the 
periphery of the mineralized matrix masses are the only ones in actual 
continuity with extracellular fluids free enough to allow ion transfer. 
PRITCHARD: Dr. Robinson, how big are those mineralized matrix 
masses? What should be one’s picture of a mineralized mass of 
crystals, and are they really crystals? 
ROBINSON: Yes; I believe they are crystals. 
PRITCHARD: Is that mass the whole mass between one blood vessel 
and the next? 
ROBINSON: No; this is extremely variable. In  some areas in bone 
the matrix is very poorly mineralized and in other areas the matrix 
is rather compact. I will discuss this subject in more detail later. 
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FIGURE IO. Bone as a physiolosic unit. [From re 
Figute 10 is a diagram illustrating the basic concept of the physiu- 
logic unit of bone (refs. 17 and 18). This concept shows the influx 
of blood and the outflow of blood; there are endothelial cells with 
a basement membrane which, incidentally, forms the container for 
the blood as it goes through the bone. Between the surfaces of these 
endothelial cells and the mineralized matrix, one can occasionally see 
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polymorphonuclear cells and a variable number of other cells. (The 
electron-microscope studies reported here were supported by Public 
Health Service, National Institutes of Health (NIH) research grant 
no. AM00706 and NIH training grant in orthopedic surgery no. TI AM 
53 17.) 
In some places, particularly on the surface of newly forming bone 
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FIGURE 1 1. An electron micrograph of the sufiace of metaphyseal trabecular bone 
from a young growing rat. On the far right Iqwer two-thirds of the figure is a 
vascular lumen. Then, proceeding to the left upper corner, one observes an 
endothelial cell (EC), several intermediate cells among which are probably some 
preosteoblasts, and then a layer of closely packed osteoblasts (OB). The osteo- 
blast cytoplasm contains a well-developed rough endoplasmic system of membranes 
(ER), mitochondria (M), a juxtanuclear Golgi apparatus (G), and a nucleus (N). 
The osteoblasts in this situation appear to form a curtain over the underlying bone 
matrix. In the left upper corner, one observes the very incompletely (spottily) 
mineralized collagenous bone matrix. However, as one can observe in figure 12, 
the mineralization becomes quite complete in this type of specimen within a few 
hundred angstroms of the collagenous periphery of the bone-matrix mass. Approx- 
imately 6780 X. [Reprinted by permission of Dr. David Cameron, University of 
Sydney, Sydney, Australia.] 
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on metaphyseal trabeculae (figs. 1 1  and 12) and along the walls of vas- 
cular canals in osteons that are actively filling (fig. 13), osteoblasts 
form a closely packed, continuous layer of cells over the bone matrix. 
However, in regions of longer standing bone matrix, the osteoblasts, 
FIGURE 12. The topography and magnification of this figure is similar to that of 
figure 11. However, in this micrograph one can observe an osteoblast becoming sur- 
rounded by bone matrix. As noted in the text, there are some round, dense masses of 
detritus overlying the cells and matrix which are probably small contaminating deposits 
of lead acetate. On close inspection these can be distinguished from the rough clusters 
of bone crystals forming spottily in the generally unmineralized bone matrix surround- 
ing the surface osteocyte and underlying the curtain of four or five osteoblasts. The 
more fully mineralized bone matrix can be seen in the left upper corner about 1 micron 
from the nucleus of the osteocyte. [Reprinted by permission 
of Dr. David Cameron, University of Sydney, Sydney, Australia.] 
Approximately 6780 X. 
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or bone-matrix-covering cells, may be strung out in a tenuous cell 
cover over this matrix. In electron micrographs of haversian canals 
in midfemoral cortex of adult dogs, there appear to be spaces between 
or fenestrations through these bone-matrix-covering cells; one would 
think these spaces might allow unobstructed contact of extracellu- 
FIGURE 13. Electron micrograph of a cross section of a haversian canal from the mid- 
diaphyseal cortex of the femur of a puppy. The dark black lines and white streaks are 
wrinkles in the section. Near the center are two red blood cells (RBC) in the lumen of 
the haversian capillary. The capillary is usually surrounded by two or three endothelial 
cells (EC).  They have a basement membrane. The intermediate cell (IC) is not 
further described because it could be a preosteoblast, a pericyte, or an extension of an 
overlapping endothelial cell. Particularly in canals in which osteoblasts (OB) appear 
to be in an active phase of protein synthesis as do those in this figure, one or more of 
these intermediate cells are seen. 
Collagen fibrils (CF) in this specimen (which was fixed in glutaraldehyde, embedded 
in Epon, and counterstained with a lead acetate solution) appear as white disks in a more 
dense (darker staining) cement substance. Also note that unlike the situation at the 
periphery of trabecular bone, bundles of collagen fibrils appear between the vascular 
space and the osteoblast curtain; occasionally mineralization is observed in these regions 
as well as in the bone matrix placed centrifugally to the osteoblasts. Approximately 
3570X. [Reprinted by permission of Dr. Reginald Cooper, University of Iowa Medical 
School. 1 
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lar fluid with bone matrix. Therefore, the cell cover is morphologi- 
cally different over the sufiace of forming and newly formed bone 
matrix and over the surface of longer standing, quiescent, or resting 
bone where there is no morphologic evidence of bone resorption or 
accretion. Of course, in vivo, this tenuous cell cover over the sur- 
face of a mass of completed and mineralized bone matrix may be a 
dynamic one with more power over the physical state of the extracel- 
lular fluid, which “laps up” on the “shore” of mineralized bone matrix 
masses, than is suggested by morphologic observations such as these. 
Such resting osteoblasts may respond in an as yet undelineated manner 
to the influence of hormones, vitamins, nerves, and chemical and pH 
changes in their environment. 
The ratio of the mass of mineralized bone matrix to the available 
crystal surfaces on its periphery is difficult to calculate for two reasons: 
first, the crystals project irregularly into extracellular and free bone 
matrix fluid along the periphery of a mass of mineralized bone matrix; 
second, the periphery of even a fully mineralized bone matrix mass 
may be, for a depth of several hundred angstroms, incompletely min- 
eralized. Therefore, one cannot exactly calculate the surface-to- 
mass ratio as one could if the surfaces of the mineralized bone matrix 
masses were smooth and if full mineralization of their bone matrix 
extended right up to those smooth surfaces. In other words, there is 
a surface roughness factor and a peripheral depth factor which make 
surface-to-mass calculations difficult. 
I attempted to estimate the apatite crystal surface area which pre- 
sents on the periphery of the mineralized bone matrix masses in the 
cortical-type regions of the skeleton in a 70-kilogram man. I con- 
cluded that there should be between 1500 and 5000 square meters 
of bone crystal surface exposed to extracellular fluid on canalicular, 
lacunar, and vascular (haversian) canal surfaces. The variable fac- 
tors of roughness and peripheral ion permeability of bone matrix 
masses tend to make this estimate of lesser magnitude than the true 
value (ref. 18). 
PRITCHARD: I was actually referring to the little units bounded 
by the canalicules. Presumably these have a voiume of the order 
of a cubic micron and a calculable external surface area. But then, 
there are the surfaces of the individual crystals inside this mass, and 
one does not know what pathways exist between these surfaces and 
the major pathways that you have shown. 
ROBINSON: That is correct in terms of direct observation. How- 
ever, on the basis of many experimental data (refs. 19 and 20), I finally 
developed a theory (ref. 17). I have chosen to call this the water- 
bridge theory. It explains the major factor governing the transit of 
calcium ions to and from the surfaces of individual apatite crystals 
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in the mineralized bone matrix masses of the skeleton (ref. 21). 
The water-bridge theory applies only directly to those ions or 
molecules that require a certain freedom of water molecules for transit 
through extravascular and extracellular fluid. For instance, this theory 
does not apply to noble gases; radon apparently does not need water 
molecules to move into and out of mineralized bone matrix. In 
relation to bone, the water-bridge theory is as follows: 
1. Bone matrix is formed by osteoblasts. When first synthesized 
prior to matrix mineralization, the matrix is highly hydrated and does not 
contain bone crystals. It does, however, per unit volume, contain 
its full complement of organic solids (ref. 22). 
2. As bone matrix mineralizes, the bone crystals displace mainly 
water, volume for volume, rather than the collagenous organic solids 
which form the bulk of the organic solids in bone matrix. In carti- 
lage (ref. 23) and possibly in bone (ref. 24) a large part of the non- 
collagenous protein, associated with the mucopolysaccharide of the 
original organic matrix, and some sulfated mucopolysaccharide are 
apparently displaced from any given volume of matrix, during min- 
eralization. Some free fibrous (collagenous) protein molecules that 
are not incorporated or adequately crosslinked into fibrils may move 
out of the matrix prior to and during mineralization. However, in 
normal bone, the collagen solids, per unit volume of bone matrix, 
are not lost during matrix mineralization. 
3. The original volume of bone matrir does not shrink or expand 
during mineralization. 
4. Bone matrix water is not completely displaced during miner- 
alization. At full mineralization, the residual bone matrix water 
becomes bound and can no longer form a water bridge for the trans- 
port of calcium ions. Each calcium ion needs, theoretically, two 
water molecules for rapid movement. These water molecules must 
have a degree of freedom not present in residual bone matrix water 
in fully mineralized bone matrix. This, of course, does not prevent 
the transit of calcium ions to the surfaces of bone matrix mineraliza- 
tion. It is our hypothesis, for instance, that diffuse exchange, at the 
light-microscope level of bone organization, in terms of 45Ca auto- 
radiographs, is actually caused by beta particles emanating from 
ions of the calcium isotope which have found or are finding their way 
via extracellular fluid to crystal surfaces on the walls of canaliculi 
which permeate the fully mineralized bone matrix. The walls of can- 
aliculi are normally fully mineralized right up to the extracellular fluid- 
mineralized matrix mass interface. Proof or rejection of this hypothe- 
sis is being pursued at present by the use of combined electron 
micrography and autoradiography (ref. 2 1). 
Part 4 of this theory applies generally to availability of mineral 
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crystal surfaces or mineral agglomerates and mineral-organic agg€om- 
erates other than crystalline, in any organic matrix, and not only in 
bone, but also in cartilage, and in ectopic sites of ossification and calci- 
fication. If there is no free water bridge in a tissue, then the ions and 
molecules that depend on this bridge for transit cannot move through 
the tissue to preferred sites of fixation or exchange. 
5 .  Implicit in this theory are the following two corollaries: 
a. The density of electrostatic forces progressively increases per 
unit volume of bone matrix as mineralization increases, limiting the 
movement through the matrix of particles carrying charges. 
b. Surface-adhering forces that are of lesser strength than electro- 
static forces and that are active even on particles not carrying a charge 
will increase per unit volume of bone matrix as crystal and fibrous pro- 
tein surfaces become crystals on the periphery of a mass of fully 
mineralized bone matrix. 
Conversely, when bone matrix mineralization is quite incomplete, 
e.g., when it contains one-half or one-tenth as much bone mineral per 
unit volume as it can contain when fully mineralized, then a water 
bridge of a sufficient number of free water molecules is present for 
the rapid transit of calcium ions to the surfaces of most of the bone 
crystals in the whole mass of quite incompletely mineralized bone 
matrix. If this volume of quite incompletely mineralized matrix is 
considerable in any one region of the skeleton, a hotspot (in terms of 
autoradiographs viewed at the light-microscope level of tissue organiza- 
tion) is present, and a region of low microradiographic density is 
present. 
In the case of the periphery of fully mineralized bone matrix masses, 
the surface consists of bone crystals and possibly some noncrystal- 
line mineral agglomerates, the surfaces of which are in continuity 
with extracellular fluid. The water molecules of the extracellular 
fluid have sufficient freedom to act as a rapid transport device for 
those ions and molecules which need free water molecules for move- 
ment. 
The periphery of a fully mineralized mass of bone matrix may be 
more or less incompletely mineralized for a varying depth. The amount 
of calcium isotope picked up on the periphery of an otherwise fully 
mineralized matrix mass will b.: dependent on the depth of the periph- 
eral zone of incomplete mineralization and is progressively more closely 
approximated as full mineralization is approached. 
These forces- the electrostatic and surface-adhering forces -are 
conceived of as halting the rapid movement of all particles, includ- 
ing residual matrix water molecules, as bone matnx achieves full 
mineralization. 
The concept of the mineralized mass is best shown in relation to 
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some work by Cooper et al. (ref. 25) on the haversian canals and their 
structure. The cortical or compact bone of the long bones of man, 
for example, is a major contributor to the total bone mass in the whole 
body. Because there are so many square meters of crystal surface 
on the periphery of fully mineralized bone matrix masses in cortical 
bone which face on intracortical vascular canals, canaliculi, and 
lacunae, one hesitates to regard this vast crystal surface-extracellu- 
lar fluid interface as an unimportant part of the mineral homeostatic 
mechanism. Osteoblasts and osteoclasts are in close proximity 
to this interface and are certainly implicated in everything that takes 
place there. 
I am concerned that metaphyseal bone, particularly that portion 
lying on the periphery of metaphyseal trabeculae, is usually consid- 
ered to play the predominant role in mineral metabolism, when the 
cortical bone forms a much greater portion of the total bone mass in 
the skeleton and presents an extensive area of bone crystal surface to 
extracellular fluid in close association with bone cells. These mor- 
phologic factors, as I see it, make cortical-type bone more important 
than trabecular-type bone in total mineral homeostasis. 
Figures 13 to 16 show electron micrographs of intracortical vas- 
cular (haversian) canals, canaliculi, and lacunae obtained from the mid- 
cortex of the femoral diaphysis of puppies and adult dogs. 
Figure 13 is a cross section of an actively filling-in haversian canal 
from a puppy. One observes the blood vessel composed of two 
or three endothelial cells. Perip5eral to this vessel along the bone 
matrix wall of the canal are several osteoblasts. One can observe the 
protoplasmic extensions from these osteoblasts extending through 
canaliculi into the bone matrix. These are particularly well seen in 
figure 14. 
The little bone crystals are located in the region of mineralized 
bone matrix. Between the osteoblasts and the mineralized portion of 
the bone matrix is a zone of nonmineralized matrix. More peripher- 
ally, one observes mineralization of the matrix. This initial mineral- 
ization is spotty and is localized in and about collagen fibrils. A few 
hundred angstroms deeper into the bone matrix the mineralization is 
more complete, and crystals obliterate the images of collagen fibrils 
and the space between the fibrils. There are about 5000 to 10000 
angstroms of matrix space between the surface of the lining cells of 
this part of this haversian canal and the more fully mineralized por- 
tion of the bone matrix mass. 
The peripheral zone of nonmineralized and partly mineralized 
bone matrix is highly hydrated. In the zone where mineralization 
of the bone matrix begins, the hydration starts to diminish and the 
crystal population starts to increase without any expansion or con- 
Homeostasis of Calcium 33 
traction of the original unmineralized volume of this matrix. As 
the mineralization becomes more and more complete, the residual 
matrix water would, according to the water bridge theory, be pro- 
gressively more bound and decreased in amount per unit volume of 
FIGURE 14. Electron micrograph in which the osteoblast-bone matrix interface at the 
periphery of a haversian canal is illustrated. At the top an osteoblast nucleus (ON) pre- 
dominates the scene. A thin zone of osteoblast cytoplasm with fingerlike projections 
borders the nucleus. The cytoplasmic projections covered by plasma membrane are 
observed to extend through lacunae into the bone matrix. The bone matrix is unmin- 
eralized close to the osteoblast, and the collagen fibrils (CF) cut transverse to their long 
axes are seen as circular zones in a more densely staining ground substance which con- 
tains Epon and was counterstained with lead acetate. The mineralization of the bone 
matrix becomes more complete as one moves farther away from the cell. The roughness 
of the mineralized periphery of the calcified matrix mass, represented by bone crystal 
clusters, and the depth factor, represented by bone matrix in which incomplete mineral- 
ization is present on the periphery of the mineralized bone matrix mass, are both obvious 
in this picture. In regions of newly mineralizing matrix it would appear that (in this 
instance under very high magnification) the cement substance between the fibrils was 
mineralizing prior to fibril mineralization. Many exceedingly small crystals can be seen 
in this region. Approximately I8 000 X. 
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bone matrix, and thereby prevent any rapid exchange of calcium 
ions between those ions on crystal surfaces in the more fully min- 
eralized region and those ions in the extracellular fluid in the unmineral- 
ized matrix region at the periphery of the haversian canal. 
There are a good many artifactual cracks in the mineralized matrix 
in our early specimens, but these cracks have been eliminated in many 
later sections of fully mineralized cortical bone by formulating the em- 
bedding medium used to infiltrate the haversian canals so that it 
equalizes any strain between itself and the surrounding fully mineral- 
ized bone matrix. 
One can see that the surface of a mineralized bone matrix mass, in 
terms of bone crystal surfaces, is anything but smooth, and that the 
phase change from nonmineralized to fully mineralized bone matrix 
may be a gradual one giving depth to the periphery of the mineralized 
bone matrix mass. 
BELANGER: Could I make a point here, Dr. Robinson? I think 
one thing that confuses people when they are talking at the same time 
of electron micrographs and microradiographs is that microradio- 
graphs are generally first image pictures, otherwise called a negative, 
whereas an electron micrograph is a photograph, or a print, so that 
what is dense, or black in your electron micrographs, is white in the 
microradiograph. I just want to clarify this point. 
TALMAGE: Dr. Robinson, these figures show primarily osteo- 
blasts bordering the canal. If these osteoblasts are actively synthe- 
sizing collagen, what prevents the center from filling in with matrix? 
How does it maintain its constant size? 
ROBINSON: As an osteon is formed, a state is reached in which no 
more closure or encroachment on the vascular space in the center of 
the osteon occurs. Equilibrium is established. 
TALMAGE: Are not the osteoblasts still synthesizing collagen? 
ROBINSON: Figure 13 happens to be from a puppy. It has ob- 
viously reached a point where, if the peripheral osteoblasts synthe- 
size much more bone matrix, they would shut off their own fuel supply. 
I think that some factor comes into play at this point which prevents 
this. 
CURREY: Are three distinct layers usually found in a fully mature. 
haversian system? 
ROBINSON: Even about the periphery of a fully mature section of 
a haversian canal one usually can find three distinguishable zones 
along some segments of its periphery (fig. 127). In this regard, great 
care must be taken during the preparation of the material to avoid 
any demineralization. When these sections of bone are produced 
by a special microtome, the section is only about 500 angstroms thick. 
These small sections float out as a ribbon over a water bath, and then 
I do not know what the factor is. 
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they are picked up on a grid. If the pH falls below about 6.8, these 
sections will demineralize very rapidly. In this work it is essential, 
therefore, to keep the pH elevated. 
Boothroyd (ref, 26) wrote a paper about this subject, and Dudley 
and Spiro (ref. 27) earlier pointed out the problem of demineralization 
on the surfaces of these matrix masses in such thin sections. Even 
with great care, one must always be suspicious that some deminerali- 
zation could have occurred. However, I think we have this prob- 
lem under control and do not feel that this area of unmineralized 
matrix is an artifact. 
ARNAUD: How do you control the problem? 
ROBINSON: We place an indicator in the fluid and we keep the 
ARNAUD: What happens if it changes? 
ROBINSON: We change our solution. As the color starts to change 
B~LANGER: Is there a possible loss at pH 7.2? 
ROBINSON: We have not seen any, whereas the loss becomes very 
dramatic below pH 6.8. 
OWEN: In figure 13 it seems as if there is a distinct boundary be- 
tween the three zones, rather than a gradual merging of the zones. 
Is this correct? 
SAXEN: Would you indicate the cell surface, or the cell membrane? 
ROBINSON: Figure 14 is a more highly magnified electron micro- 
graph than figure 13, and shows more clearly the plasma membrane of 
the osteoblast in relation to the bone matrix. This figure shows the 
plasma membrane covering the protoplasmic extensions of the cell 
which proceed into the bone matrix. 
The crystal masses start to form spottily through the mineralized 
zone. Nevertheless, there is a clear demarcation from the next 
zone, in which mineralization is fairly good, but definitely incomplete 
in some areas; then, in the next zone mineralization is suddenly quite 
complete. 
BUDY: In figure 14, what are the vacuoles below, above, or in 
between the mineralized area? 
ROBINSON: Those are collagen fibrils, and the space between the 
fibrils is more dense in this micrograph than the fibrils themselves. 
This may be because the embedding media picked up some of the 
lead counterstain, whereas the fibrils themselves did not pick up so 
much. 
If the mineralization were all peripheral to the collagen fibrils, one 
would see holes the size of the collagen fibrils throughout the min- 
eralized matrix mass when the mineralized matrix mass is sectioned 
transverse to the long axis of the collagen fibrils. We have not seen 
pH at 7.2. 
we change our solution. 
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these holes, and this is one of the major arguments for the belief that 
these mineral crystals occupy space in the fibrils, as well as around the 
fibrils in the mineralizing region. 
PECK: You cannot exclude the possibility, though, that those spaces 
are occupied by lipid. 
ROBINSON: The collagen fibrils are laid down around the osteo- 
blasts that line the haversian canal. These osteoblasts are laying 
down the fibrils in one direction, but apparently every few hours they 
switch the collagen axis and lay them down more or less at right angles 
to the previous direction. The fibrils are usually more osmiophilic 
than the material in the regions between them. Therefore, I have no 
evidence that there is much lipid present. 
MACDONALD: r. Robinson, would you say this is evidence that 
calcification not only occurs at the surface of the mineralization front, 
but also can occur at random in the matrix above it? 
ROBINSON: That is correct. The mineralization front is not observed 
to be a straight line that moves from the fully mineralized matrix 
into the newly formed matrix. Rather, mineralization first appears 
spottily throughout the newly formed matrix. The cell produces 
the matrix; then there is a lag period. This lag period can be ex- 
tended in several situations. One of the most clinically outstanding 
situations is the fracture callus, where a great deal of matrix mass may 
be formed before mineralization appears. 
Cameron has mentioned this (ref. 28), particularly in the fracture 
callus of the rat. 
NICHOLS: How does the mineral get there, by diffusion? 
ROBINSON: Right. First, the matrix mass does not decrease or in- 
crease in volume during mineralization, and second, the density in- 
creases rather suddenly in those particular regions where mineral- 
ization is occurring. This increase implies diffusion of mineral ions 
into crystal nucleation sites at the time of mineralization and not sig- 
nificantly before. On the basis of electron micrographs of mineraliz- 
ing matrices of epiphyseal cartilage and of bone, as previously noted 
(refs. 21 and 29), an amorphous “cloud” more dense than the sur- 
rounding ground substance seemed to appear about a portion of 
one collagen fibril or about adjacent portions of several fibrils. It 
was in this cloud and in relation to a collagen fibril that the first crys- 
:tals seemed to appear. The most logical explanation is that a chem- 
ical change occurs in a portion of the newly formed bone matrix. 
This change involves the collagen and a surrounding portion of ground 
substance. The altered portion of the bone matrix then becomes 
a “trap” for calcium and phosphate ions. Diffusion into this trap 
is possible because the water bridge for calcium ions is open between 
the matrix trap and the vascular space. 
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In 1963 I speculated that an enzyme produced by a cell might, as 
suggested by Campo (ref. 23), split the noncollagenous protein from 
the mucopolysaccharide, permitting chondroitin sulfate to act as a 
calcium trap while the adjacent collagen fibril became a phosphate 
trap (ref. 30). 
If the calcium ions were already in the matrix and if only the water 
was removed at the time of mineralization, a vacuum would be formed 
or the matrix would decrease in volume. Furthermore, if calcium 
ions were already in newly formed bone matrix at a density even 
approaching the density they assume during apatite crystal formation, 
microradiographs of freeze-dried bone and microchemical analyses 
should show their presence, but they do not (ref. 24). 
It appears to me that the mineralization process is instituted in bone 
matrix subsequent to bone matrix formation and by a quite separate 
mechanism. During this process the mineral ions mainly replace the 
matrix water, volume for volume, as they concentrate in the organic 
matrix focally and form hydroxyapatite crystals. These ions must 
diffuse into the matrix during the mineralization process and not 
significantly before. 
This organic matrix mass produced by the osteoblasts has a high 
water content. The extracellular, extravascular fluid is conceived 
to form a water bridge from the vascular space right into this newly 
formed bone matrix. Thus, rapid diffusion of ions, such as those of 
calcium, is possible prior to matrix mineralization and during matrix 
mineralization. This diffusion slows as full mineralization is ap- 
proached. 
Your 
theory would seem correct, except that it must be remembered that 
the matrix is laid down by cells in a fluid atmosphere which contains 
ions; suddenly, something happens so that these ions aggregate into 
crystals. It seems to me that at this time one of several things may 
have happened. It could be that it starts very full of water, as your 
studies show, and something pumps out the water, leaving the silt to 
accumulate to the point where the mineral precipitates. A second 
possibility is that something is happening to that matrix which is 
modifying it in situ, or maturing it. There might be a crosslinking 
or some extracellular enzymatic processes going on (refs. 31 and 32). 
The third possibility is that the cells located at the site “get the word” 
and start pumping ions into the area, instead of their pumping water 
out of the area. It seems to me that one should believe in one of these 
three possibilities. 
BELANGER: There may be a possibility also that a local change in the 
pH would be attributable not to the collagen but to the rest of the 
organic matrix, particularly the mucopolysaccharides. This is known 
NICHOLS: I would like to start a discussion on this point. 
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by the histochemical approach. The mucopolysaccharides that are 
close to the surface are mostly of the acidic variety, while those more 
centrally located seem to respond better to methods such as the periodic 
acid-Schiff, which indicates a neutral variety. 
NICHOLS: Could you define what you mean by central and peripheral? 
BELANCER: Yes. What is away from the osteoblast I call more 
central, and what is closer to the cell I call peripheral. In this bone, 
which Dr. McLean calls “prebone,” are found a number of these 
acidic-staining mucopolysaccharides. This is like the situation in 
young cartilage; calcification cannot occur in this area because of the 
environment and the low pH. But as one moves away from this area 
and the cells become older, the tissue can make no more of them. 
When the cell is older and more mature, it acquires equipment to make 
other types of mucopolysaccharides; consequently, I think Dr. Robin- 
son is right to think that collagen is far from being the only factor 
involved in the secretion of the cells away from the surface. 
NICHOLS: When you say “more acidic,” do you mean there is more 
bound sulfate at the cell surface? 
BELANCER: This is one type. This is one way of defining these 
typical mucopolysaccharides. Another way of looking at them is 
that they would have other acidic groups apart from sulfates. 
e mucopolysaccharides 
become neutral. 
I do not say that they do become 
neutral. But if this environment is constantly changing, it is changing 
under the influence of the cells which are located in one part or another 
of the bone. The cells at the surface possibly can make more muco- 
polysaccharides with sulfate than the cells which are deeper inside; 
the osteocytes which, because they are more mature, can now make 
more of another type which is more neutral, and will change from one 
area of bone to another. 
NICHOLS: I think Dr. Howell has some data which bear on this 
subject. 
HOWELL: Dr. Nichols was referring to our pH measurements on 
an essentially extracellular fluid phase sampled from normal and 
rachitic rats in vivo by a micropuncture technique to be described 
later. The fluid samples, about 20 mpl, have been shown to originate 
from the hypertrophic cell cartilage; that is, predominantly, we believe, 
from or close to histologic sites of calcification. With precautions 
to prevent loss of CO, the pH is measured directly with microelec- 
trodes on such fluid sampled before and after various measures to 
promote calcification. Prior to healing, pH recordings in the fluid 
have been 7.45 to 7.55; during healing these readings increased to 7.50 
to 7.58, the same as for fluid aspirated from normal cartilage plates 
NICHOLS: Then you have to explain wh 
BELANCER: I cannot explain that. 
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or from perichondrial “lymph” on rachitic cartilage plates. We think 
that our model of endochondral calcification may have an important 
bearing on mineral transfers in bone matrix. 
HOLTZER: Is not this point leading up to something; namely, that 
the cell knows what is top and bottom and what is right and left? The 
polarization of the osteocytes is exceedingly relevant. It is clear that 
the cell does not want to make collagen in the area facing the crystalliza- 
tion zone, In short, the whole system is spatially oriented. The cell 
is commanding and determining where and when things are to occur 
both inside and, probably indirectly, outside the cell. To visualize 
this as simple precipitation in an ionic cloud would be denied by that 
very photograph (fig. 14), although later you might find that the cell 
decided that what is left field will not be right field. In short, when 
the cell is completely surrounded by matrix, something must happen 
to that cell and it says, “Now instead of sending collagen off to the 
right I am going to send it, or its precursor, off to the left.” 
NICHOLS: I think your point is very well taken, but there is another 
factor that I would like Dr. Belanger to comment upon. I also think 
that there is a change in pH, and I should have included it. I wonder 
what role the glycolytic metabolism of these cells may play in this 
whole process. One can explain the failure of mineral precipitation 
of nucleation by simply invoking a lower pH around the cells without 
involving sulfation at all. All that is needed is a cell that happens to 
excrete a lot of organic acid, which we now know these cells do. 
ROBINSON: I would like to complete the rest of the picture of this 
matrix mass surface and point out the roughness factor of the periphery 
of the matrix mass available to extracellular fluid on the walls of 
lacunae and canaliculi. 
Figure 15 shows an osteocyte in a lacuna in a quite completely 
mineralized mass of bone matrix. This osteocyte is not very close 
to a periosteal, endosteal, or vascular canal surface; it is quite deeply 
buried. Osteocytes in such a position show atrophy of their cyto- 
plasmic organelles; e.g., endoplasmic reticulum membrane system 
and mitochondria. The cells occupy less of the lacunar space. The 
matrix bordering the lacuna is apt to be more completely mineralized, 
although along one edge of this lacuna some unmineralized collagen 
fibrils are present. The extracellular fluid space between the cell 
and the bone matrix wall of the lacuna is greater than that about a 
newly buried surface osteocyte. (See fig. 12.) Note that at the 
electron-microscope level of tissue organization, the crystals produce 
a fairly rough and irregular surface along the periphery of the lacuna. 
The protoplasmic-cell extensions can be seen proceeding out from 
the cell body toward the bone matrix, and one of these in figure 15 can 
be observed particularly well. The protoplasmic extensions do not 
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FIGURE 15. Electron micrograph of a deeply buried osteocyte in the periphery of 
a well-mineralized osteon in the midcortex of the diaphysis of the femur of an adult 
dog. These osteocytes, unlike the surface osteocytes illustrated in figure 12, show 
atrophy of the rough endoplasmic reticular membrane system and a marked reduc- 
tion in number of mitochondria. Unmineralized collagenous fibrils are seen along 
the periphery of this lacuna, although unmineralized matrix is near minimum in this 
particular situation. The cell extension can be seen passing up to the top of the 
figure on the left. Approximately 6780 X. 
completely fill the canals in which they lie; there is always a small 
extracellular space between the plasma membrane that surrounds 
each one and the mineralized matrix wall of the canal. Baud (ref. 33) 
also found this space between mineralized matrix and the tube of cell 
membrane in canaliculi. 
CURREY: This is not a fixation artifact? Can you be sure of that? 
ROBINSON: I do not think this is an artifact. Lipp (ref. 34) in exten- 
sive light-microscope histochemical studies, demonstrated a sleeve of 
material in this region of canaliculi between cell membrane and bone 
matrix which had a high mucopolysaccharide content. 
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Figure 16 is a cross-sectional view of several canaliculi in quite fully 
mineralized bone matrix. It is interesting that one often sees two 
protoplasmic extensions in one canal in canine bone. We have 
searched for the junctions between the protoplasmic processes of 
osteocytes, and osteocytes and osteoblasts in canaliculi, and we have 
observed several of these (ref. 25). We have seen no specialized 
areas, such as desmosomes, on abutting plasma membranes of the two 
bone cells, but we have seen such specialized regions of cell membrane 
at the contact areas of endothelial cells. (See fig. 128.) 
FIGURE 16. Fully mineralized bone matrix from the cortex of dog femoral diaphysis. 
The canaliculi are obvious. Many contain two cell extensions. The extracellular 
fluid space about these extensions is the clear white space between them and the black 
mineralized matrix. The collagen periodicity is emphasized in this very thin section 
by tiny bone crystals in the fibrils. Fascicules of larger and more compactly arranged 
crystals can also be seen paralleling the fiber axis; they are thought to be between the 
collagen fibrils. Approximately 12 000 X. 
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Note the roughness of the surface of the canalicular wall produced 
by the little crystals in the periphery of the mineralized bone matrix. 
On the other hand, one should note that the mineralization of the bone 
matrix extends right up to the edge of the bone matrix on these canal 
walls, and unmineralized collagen fibrils are not observed along the 
walls of these canals in normal dog bone. However, along the walls 
of haversian canals and lacunae some unmineralized bone matrix is 
usually seen. 
In contrast to this region of quite full mineralization of bone matrix 
in the middle of the cortex of a dog femoral diaphysis, I should like to 
return to Dr. Cameron's electron micrographs (figs. 11 and 12), where 
one can observe newly formed bone matrix very well. They happen 
to be from the surface of a metaphyseal trabecula of a growing rat, 
but they are good examples of partly mineralized bone matrix. In 
the areas of very incomplete bone matrix mineralization between foci 
of mineralization, many of the crystal surfaces are available. How- 
ever, when mineralization is quite complete, we believe that the surfaces * 
are no longer available because they have been shut off from rapid 
diffusion of calcium ions by, for example, the very fact that the water ' 
bridges necessary for the transit of these ions have been obliterated. 
However, in these incompletely mineralized areas, the water bridge 
is still open between vessel and crystal surface. 
It is in these regions that tetracycline molecules and calcium ions 
are known to be deposited. We feel that the mechanism is quite 
simple; namely, that as long as a water bridge extends to the crystal 
surface, then the ion or molecule that has some chemotactic attraction 
for the crystal surface can reach the crystal surface until mineralization 
approaches completion. In other words, even just the surface of the 
mineralized matrix is a hotspot, but it is only a hotspot in a shallow 
sense. When very incomplete mineralization extends deeply enough 
through a bone matrix region, then you have water bridges in depth 
to all of the crystal surfaces, and you have what is known as a hotspot 
in autoradiographs as viewed in the light microscope. 
HOLTZER: In figure 12, must you not postulate that there is actually 
an inhibitor here? I am amazed to see how close the crystalline area 
approximates the cell membrane of the cell top. There is a collagen 
layer, presumably, on the cell bottom. 
ROBINSON: This cell used to be an osteoblast, and it is being hemmed 
in. This cell is creating a new matrix in this region. 
HOLTZER: Yes. There must be a zone that actually cannot calcify. 
URIST: What is the composition of the osteoid seam? 
ROBINSON: It is collagen, water, and mucopolysaccharides. 
URIST: Is this area filled with crystalline calcium phosphate? Is 
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it possible that this space could have been filled with noncrystalline 
calcium phosphate? 
ROBINSON: I would like to postpone an answer to that; however, I 
will tell you what I feel. 
We held up one paper for publication for a long time to test this 
point. After injecting calcium tracer into the heart of a rat and sacri- 
ficing the rat, we took slices of the tibia. We sacrificed at two time 
intervals, one at 2 minutes and another at 2 hours. The tracer calcium, 
we would think if it were going to such a pool of ions, would be quite 
readily soluble in the fixatives or in a fluid which is used in a dehydration 
bath. 
URIST: Was the tissue fixed in osmic acid? 
ROBINSON: No; in glutaraldehyde. 
URIST: What was the pH of the solution? 
ROBINSON: We never use a fixative with a pH below 7.2 whether 
we use glitaraldehyde or osmic acid. Both are buffered. Incidentally, 
if phosphate buffers are used some very peculiar pictures are obtained, 
so you must still be careful not to use phosphate buffers. 
URIST: What kind of peculiar pictures? 
ROBINSON: We start to see a great deal of mineralization in this 
area of unmineralized collagen. 
URIST: The question is, Is there a physiologic osteoid? Does this 
physiologic osteoid represent collagenous matrix that contained 
noncrystalline calcium phosphate? The significant statement that 
you have made about the pH of your fixative would suggest that if such 
a thing does exist it would be soluble at pH 7.2. Are there calcium 
phosphates that are soluble at pH 7.2? 
Electron micrographs do not answer Dr. Bauer’s question about 
whether mineral in vivo is or is not crystalline. I think you have shown, 
and I agree, that bone mineral is crystalline, but I wonder if a non- 
crystalline material might occupy the osteoid seam. In addition to 
such factors as pH of the solution, is it necessary to take into considera- 
tion such factors as leaching of loosely bound deposits of mineral? 
ROBINSON: If this substance exists in any concentration, one would 
expect that it would show up as greater density in this area. Therefore, 
we did this experiment that I just described. It is true that when you 
take sections of the tibia at 2 minutes, collect all the fixative dehydration 
baths, at the end of that dehydration take the remaining sample and 
demineralize it, put the solutions onto planchets, and count the total 
radioactivity of the solution, you find that in the 2-minute specimen 
you lose about 16 percent of the total radioactive calcium. At 2 hours, 
it is less than 1 percent. 
In view of this experiment-and admitting that this is only one 
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experiment-I do not feel that the preparation method washes out a 
significant amount of calcium from that space. 
URIST: Have you done an experiment in which you have measured 
the calcium content of the fixative? 
ROBINSON: Yes; and also measured that of the total specimen. 
URIST: So that you would account for all the calcium that was there, 
and you would account for the calcium that could have come off in 
the fixative; and thereby, you feel that you have excluded the possibility 
of noncrystalline calcium phosphate in the tissues? 
I do not feel that we are losing any significant 
quantity of calcium, because at 2 minutes after injection into the 
bloodstream there is still a good deal of the calcium in the extracellular 
fluid and in the vascular and marrow spaces; this calcium has not yet 
reached a crystal nucleation locus or the surface of a crystal in the 
bone. The reason we performed this experiment was that we had noted 
that as early as 2 minutes after the injection of the isotope, it was 
largely associated on autoradiographs with the crystalline material 
that we see on the periphery of the mineralized bone matrix masses, 
and not in that area between the cells and the crystals. I cannot say 
that we do not have a load of calcium, perhaps, attached to a muco- 
polysaccharide in this area between the bone cell and the bone crystals 
in the mineralized bone matrix; but I think this experiment counteracts 
to some extent the arguments that we are washing out a large quantity 
of calcium and that we are not getting a good representation of what 
really occurs in combined autoradiographs and electron micrographs 
in regions of mineralizing bone matrix. 
URIST: I do not think we are inquiring about a large amount of 
calcium phosphate. I am inquiring about whether there is a critical 
transitional phase that is leached out of the tissue. 
COPP: I think that you are both right. There could be calcium and 
phosphate in the space between the cell and the crystals which could 
be washed out, but we do not know how much. 
ROBINSON: Obviously, calcium ions have to pass through the space 
from the vessel to crystal nucleation sites in bone matrix, but we 
doubt that calcium is concentrated in large amounts in the bone cells 
or throughout the unmineralized bone matrix prior to its demand at 
crystal nucleation sites in specific regions of the mineralizing bone 
matrix. 
PRITCHARD: Some years ago Homing (personal communication), 
using microincineration, found a surprising amount of calcium in 
osteoid. I remember thinking there must have been a mistake; but 
it was true. 
ROBINSON: No. 
COPP: Obviously this is a transitional stage. 
URIST: This question is a very important part of the subject of 
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calcium homeostasis. A recent paper by Kashiwa (ref. 35) purports 
to show that with the dye, glyoxal bis(2-hydroxyanil), known as GBHA, 
it is possible to demonstrate calcium in noncrystalline form in the 
proteinaceous material in the cytoplasm of osteoblasts and osteocytes. 
If this is true, it means a whole new area containing a small, but critical, 
fraction of the total body calcium is present in bone cells. The amount 
present in osteoid seams is not revealed because the stain does not 
fix calcium phosphate complexes or apatite. 
Dr. H. K. Kashiwa was invited to the Bone Research Laboratory at 
UCLA to give instructions on his method, and we learned that he was 
using high concentrations of GBHA to stain whole mounts of the bone 
of the rat calvaria. I made thin sections of undecalcified bone and 
preparations of tendon with and without tendon-calcium ion complexes; 
I stained them by Kashiwa’s technique, except with only one-tenth of 
the concentration that he employed, and obtained the photomicrographs 
shown in figures 17(a) and (b),  and 18(a) and (b). 
The dark-red staining, insoluble calcium-GBH A complex could be 
observed in the cytoplasm of osteoblasts and osteocytes; the osteoid 
seams and the calcified intercellular matrix were unstained (fig. 17). 
FIGURE 17. Photomicrographs of undecalcified sections of ( { I )  tibial shaft cortex and 
(b) epiphyseal cartilage from a newborn rabbit. The sections were stained with a dilute 
solution of GBHA. 
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FIGURE 18. Photomicrographs of rat-tail tendon treated with (a) CaCI, and (b) CaClr 
and phosphate buffer, The sections were then stained with GBHA. 
The GBHA also stained the cytoplasm of chondrocytes (fig. 17(b)). 
The chondrocytes may be secreting a fibrous protein-calcium complex 
similar to that shown in figure 18(a). The calcium in uncalcified 
cartilage matrix or apatite in cartilage matrix is not available for reaction 
with GBHA under these conditions. 
Rat tail tendon, treated with 5 millimoles per liter of CaC12, is stained 
a deep red by a dilute solution of GBHA (fig. 18(a)). The tendon- 
collagen-calcium complex binds GBHA in an insoluble precipitate. 
Tendon untreated with calcium is unstained or weakly stained with 
GBHA. The tripartite tendon-calcium-phosphate complex does not 
stain with GBHA when tendon collagen is treated first with CaCl, 
and then with phosphate buffer, 5 millimoles per liter (fig. 1 8(b)). The 
affinity of phosphate for calcium is greater than that of GBHA when low 
concentrations of the stain are employed. 
COPP: I think Dr. Howell has some data on this point. 
HOWELL: Cartilage data show this increase in calcification up to 
the ossification process. 
COPP: Dr. Robinson’s magnificent electron micrographs of bone 
have given us some idea of the problems and interactions between 
bone mineral and extracellular fluid. We have found, for example, 
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that the plasma calcium dropped 30 percent after thyroparathyroidec- 
tomy in the rat, and there was a corresponding drop in exchangeable 
bone calcium (ref. 36). 
BAUER: That is your computation from the accretion rate? 
COPP: The accretion rate also changed. 
BAUER: I wonder if there is any experimental evidence that altera- 
tions in exchangeable bone calcium do occur. You say that the accre- 
tion-resorption rate did not change. However, I think it is right to 
say that no one has seen a change in the exchangeable amounts without 
some change in the accretion-resorption, so it is more of a concept 
than actually based on evidence. 
When calcium is injected into a thyropara- 
thyroidectomized dog, as in figure 19, a new equilibrium is reached 
at a higher plasma calcium level. There is a corresponding increase 
in the labile bone calcium pool, which we estimate to be 50 to 80 mg/kg. 
COPP: I do not agree. 
mg % Ca 
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FIGURE 19. Increase in the equilibrium level for plasma calcium 
after intravenous infusion of calcium (101 mg/kg) into a dog thyro- 
parathyroidectomized 1 week earlier. The dog also received a 
dose of parathyroid extract suMicient to raise the plasma level 
I mg/100 ml, as indicated by the broken line. 
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BAUER: I had estimated it to be 5 grams per 100 units. 
COPP: No. We estimate the pool on the basis of body weight, and 
it is interesting to note that our estimate agrees quite well with your 
estimates of exchangeable calcium as measured with radioactive 
isotopes. 
CURREY: I would like to ask a question about this labile pool which 
I do not quite understand. It seems to me that the labile pool is a 
surface phenomenon; therefore, why do you say that the amount in 
the labile pool is a measure of change? 
COPP: Your point is well taken. The pool really represents a 
volume capacity; assuming arbitrarily that the concentration of cal- 
cium in this labile bone storage pool is the same as in plasma, we would 
estimate a pool size of 500 to 800 mg/kg body weight. At a normal 
plasma calcium level of 10 mg/100 ml, the amount of calcium in this 
pool would be 50 to 80 mg/kg. Assuming the capacity of this pool 
is unchanged, an increase of 2 mg1100 ml in plasma calcium would 
correspond to an increase to 16 mg/kg in the calcium in this pool. 
There are two distinct and different points of view with respect 
to the exchange between the calcium in bone and the calcium in extra- 
cellular fluid. We may not be able to resolve these differences in the 
time available, but they should be clearly stated. 
Our point of view is that those crystals of bone salt which are 
accessible to the circulation act like an ion exchange column, with 
calcium on the surface of the crystals exchanging with the calcium in 
the surrounding fluid by a purely physicochemical process. This 
would correspond”with the almost universal uptake of 45Ca around all 
the vascular channels of bone observed by Dr. Rowland a few minutes 
after injection of the isotope. As with any ion-exchange column, 
if the ionic concentration of calcium in the fluid increases, the concen- 
tration of calcium on the crystal surface will increase. This, we feel, 
corresponds to our labile bone storage pool for calcium. The other 
view holds that there is a regulating biologic membrane separating 
all bone mineral from the surrounding fluid; the level of calcium in the 
fluid depends on this membrane and the effect that the calcium active 
hormones have on it. In both cases, it is agreed that there are biologi- 
cally active and hormone modified processes of accretion and resorp- 
tion which determine the ultimate calcium balance between bone and 
body fluids. 
ARNAUD: I do not think that we have enough information or the 
techniques to distinguish adequately between these processes. 
COPP: Dr. Talmage .would like me to mention the parathyroids, 
which he thinks are related to calcium homeostasis. Their importance 
was indicated by the classic work of Hastings and Huggins (ref. 37). 
The brilliant hypothesis of McLean (ref. 38), and the experiments 
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FIGURE 20. Typical response of systemic plasma calcium and phosphate levels to 
perfusion of parathyroid with blood to which calcium or EDTA has been added. Dotted 
line shows changes in the same dog when parathyroid extract (PTE) (20 unitslkglhr) was 
injected for a 3-hour period 6 hours after thyroparathyroidectomy. [From ref. 39; 
reprinted by permission of the publisher.] 
of Copp and Davidson (ref. 39), clearly showed that this was accom- 
plished by negative feedback control. When the thyroid and para- 
thyroid glands of a dog (fig. 20) were perfused with blood low in calcium, 
there was a rise in systemic plasma calcium which closely resembled 
the response obtained in the same animal with continuous intravenous 
infusion of 20 units/kg/hour of parathyroid extract. This is approxi- 
mately 200 times the maintenance output of the parathyroid hormone 
as determined by us in previous experiments (ref. 13). These values 
are generally in line with the observations of Sherwood et al. (ref. 40) 
and Care et al. (ref. 41) on parathyroid hormone production in cows, 
sheep, and goats in which the glands were stimulated or inhibited by 
injection of EDTA or calcium. The hormone in plasma was deter- 
mined by radioimmunoassay. 
In our studies on perfusion of the isolated glands and in studies 
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on increased mobilization of calcium during calcium infusion, as 
shown in figure 21 (ref. 42), it is apparent that a fall of as little as 10 
to 15 percent in the level of calcium in the blood passing through the 
gland is sufficient to stimulate hormone production. 
Parathyroids Intact 0- ---0 
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FIGURE 2 I .  Effect of EDTA infusion on plasma calcium level in the same animal with 
intact glands (broken line) and after removal of the thyroid and parathyroids immediately 
after EDTA infusion as indicated by the arrow. [Adapted from ref. 42; reprinted by 
permission of the publisher.] 
Dr. Raisz has done some beautiful studies on the effect of the calcium 
concentration on parathyroid cells in organ cultures (ref. 43). Dr. 
Raisz, would you comment on this work? 
RAISZ: I think we are now at the point where an elegant servo- 
analysis of calcium homeostasis could be achieved if we could get 
precise-enough data to satisfy mathematicians. One of the difficulties 
in a biologist's work is that he can never satisfy the mathematical 
demands for large numbers of points, but he can make an attempt. I 
think a model, on the basis of which we can make a specific analysis, 
is available. I would like to make the simplifying assumption- which 
we can debate-that the controlling system in calcium regulation is 
bone resorption and not bone formation. Bone formation is likely 
to be controlled by matrix synthesis, by hormones which regulate 
bone growth, and by local factors which determine the structures of 
bone; one might call these the orthopedic functions of bone. 
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NICHOLS: When you speak of “bone resorption,” do you mean both 
mineral and matrix or just mineral? 
RAISZ: I will talk about mineral, but it is obvious that one cannot 
remove adequate amounts of mineral from bone without getting rid 
of some of the matrix. 
URIST: Are you referring to second-to-second control of calcium 
homeostasis? 
RAISZ: No. 
URIST: Is matrix formation involved in second-to-second control? 
PARATHYROID 
c**- 
FIGURE 22. Illustration of the simplest 
model for feedback regulation of blood 
calcium ion concentration in which bone 
resorption is the major controlling sys- 
tem. In  addition to the feedback con- 
trol of parathyroid hormone, the possible 
role of thyrocalcitonin is indicated. 
RAISZ: No; it is not. 
URIST: I would think certainly hour-to-hour control required matrix 
formation, and that you are correct in assuming that second-to-second 
control is a function of the mineralized surfaces. 
RAISZ: Given bone resorption as a controlling system and calcium 
ion as the controlled system, we have, in the McLean hypothesis, 
negative feedback control through parathyroid hormone which is 
constantly secreted and stimulates bone resorption. These are all 
things we have known since the 1920’s. (See fig. 22.) Now we can 
ask what kind of control this is. We have only fragmentary evidence 
at present, but as investigators get better at studying the way in which 
the parathyroid gland responds to calcium, they can ask questions of the 
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FIGURE 23 .  Effect of calcium concentration on tissuelmedium concentration ratio of 
14C-zlpha-aminoisobutyric acid after 2-hour incubation. Points are mean values with 
SE. Number of observations is given in parentheses. [From ref. 44; reprinted by 
permission of the publisher.] 
kind which have been asked about such feedback mechanisms as the 
carotid sinus control of blood pressure. For example, is there an 
amplified proportional control whereby small changes in calcium level 
cause proportionately large changes in parathyroid hormone output? 
I think we can assume that parathyroid hormone has two ways of 
functioning. One is an amplified proportional feedback which responds 
to minute-to-minute changes in serum calcium concentration, both by 
changes in secretion and changes in hormone synthesis. The second 
is an integral response which requires growth of new cells or possibly 
involves activation of cells which have been in a quiescent condition. 
These are probably general phenomena of endocrinology. This is illus- 
trated by the feedback control of the uptake of alpha-aminoisobutyric 
acid (AIB), a nonmetabolized amino acid analog which is actively 
transported into the cells by the system responsible for the uptake of 
the natural amino acid, glycine (ref. 44) (fig. 23). These data were 
obtained from isolated rat parathyroid glands incubated for 2 hours at 
varying calcium concentrations. Normal calcium concentration 
would be about 1.5 mM. Between l/2 and 1 Y2 times this concentration, 
there is a steep curve relating AIB uptake inversely to calcium con- 
centration. With lower or higher concentrations beyond this range, 
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there is little further change in AIB uptake. These data, then, follow 
an S-shaped curve which (while not as clear cut as the data for the 
carotid sinus regulation of blood pressure) does indicate a proportional 
response of the parathyroid to calcium concentration which is amplified 
around the normal calcium concentration of blood. To prove this. 
extensive data on the effect of calcium on the rate of secretion in vivo 
will be required. Assuming that such a response exists, maximal 
stimulation occurs at half normal calcium concentrations; the only 
way in which the parathyroid can respond further to prolonged stimula- 
tion would be to increase its functional tissue mass. Figures 24 to 26 
illustrate such a response. The model is the vitamin-D-deficient rat 
in which, because of end organ failure, Le., the inability of bone tissue 
to respond to parathyroid hormone, one can see prolonged hypocal- 
cemia over many days (ref. 45). With hypocalcemia there is an 
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FIGURE 24. Relationship between serum calcium concentration and parathyroid uptake 
of AIB expressed as the ratio of AIB concentration in parathyroid tissue water to that 
in serum (T/S ratio) at equilibrium 24 hours after AIB injection. Each symbol rep- 
resents mean and SE for both serum calcium concentration and parathyroid AIB uptake. 
Figures in parentheses represent number of animals in each group. Symbols for dif- 
ferent diets are indicated in figure 25. [From ref. 45; reprinted by permission of the 
publisher.] 
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increase in parathyroid AIB uptake as the serum calcium falls to 6 
mgl100 ml (fig. 24). With further lowering of serum calcium, achieved 
by combining vitamin D deficiency with a low calcium intake, the 
serum calcium falls still further, but there is no further increase in the 
function of the tissue as indicated by the AIB uptake. However, the 
gland can respond by getting bigger. Figure 25 illustrates the inverse 
relationship between parathyroid size and serum calcium for both 
dietary changes in calcium and for the effects of vitamin D deficiency. 
At the risk of overanalyzing our data, we. have taken the 'activity of 
the gland, as measured by amino acid uptake, and the size of the gland, 
multiplied them together, and divided by body weight to obtain a 
parathyroid activity index. Figure 26 illustrates the remarkably good 
inverse linear correlation between calcium concentration and the 
parathyroid activity index. This linear response is a reflection of 
integral control. That is to say, not only is the change in serum cal- 
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FIGURE 26. The relationship between serum calcium concentration and parathyroid 
activity index (PAI). PA1 is calculated as the T/S 
ratio times parathyroid size divided by body weight. This index combines the effect, 
by any given experimental procedure, on size and activity of the parathyroid and cor- 
rects for any difference in body size. [From ref. 45; reprinted by permission of the 
publisher.] 
Symbols are defined in figure 25. 
cium responded to proportionally but the prolonged duration of that 
change is able to alter the amount of functioning parathyroid cell mass. 
Thus, by increasing both activity and amount of tissue, we can greatly 
increase the total parathyroid response. I suppose there must be a 
limit, perhaps when the parathyroids become larger than the rat, but 
there appears to be a great capacity for an integral control in the 
parathyroids. 
FREMONT-SMITH: What is your AIB? 
RAISZ: Very good. Alpha-aminoisobutyric acid, which is non- 
metabolized. That is the ami'no acid transport system largely for 
glycine. The shocking level is up to about half normal. Normal 
would be about 1.5 millimoles per liter. Shocking level up to half 
normal has no consistent steps. Between l/z normal and 1 %  times 
31 1-496 0-68-5 
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normal shocking level, one has a deep curve relating inversely to 
shocking concentration. 
I would like to 
see data on normal secretion in vivo which would show, I believe, that 
the greater secretion changes rapidly; that is, the proportional response 
to the parathyroid is amplified around the normal calcium level, just as 
the response of the carotid sinus is amplified around normal blood 
pressure, but proceeding with greater regulation toward normal. 
Assuming for the moment that this is likely to be true about the 
parathyroid, that will answer the problem of prolonged stimulation. 
HOLTZER: As you say, that is really tremendous. Have you 
checked that out as to the number of cells on the surfaces, for example. 
RAISZ: We have shown that low calcium increases RNA synthesis 
in tissue culture. 
HOLTZER: This ought to be DNA; that is the whole point. 
RAISZ: We have done no direct DNA studies. With embryonic 
tissue one gets an increase in mitoses and in the number of cells. We 
have not been able to get many mitoses in adult rat parathyroids in 
tissue culture, but we know that this can happen in vivo from the 
stii-dies of Talmage and Toft (ref. 46). 
NICHOLS: I think that there is reasonable, although less direct, 
confirmation of these views in human material. 
First, there are people with uremia in whom there are hypertrophied 
parathyroids which are very large indeed and, by inference, there are 
more cells present. Evidence is also available from such patients, 
which suggests that these glands revert toward normal. If a successful 
kidney transplant, which functions for several months, is achieved, 
the serum calcium of these patients returns to normal. Indeed, 
if they have metastatic calcification, this disappears. In the one 
patient I know of, who has since come to post mortem, the parathyroids 
were normal (ref. 47). 
RAISZ: I would like to point out that the other half of the regulation 
still requires further study; that is, the opposite effects of thyrocal- 
citonin. I do think that the same kind of approach can be made to 
studies of thyrocalcitonin regulation. 
COPP: The only thing I would do would be to twist it the other way 
around. We hope to do the experiment you mentioned, and measure 
the enhanced parathyroid hormone output by immunoassay during 
EDTA-induced hypocalcemia. 
MCLEAN: Before you go on with thyrocalcitonin, I would like to 
add another human model to the one Dr. Nichols has mentioned. 
This is a situation in which there is an adenoma of one of the para- 
thyroids, and the other parathyroid glands are exposed to hypercalcemia 
over a long period of time. This is being intensively studied now and it 
We still need to obtain data on AIB uptake in vivo. 
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will add a great deal to our understanding of the control of parathyroid 
secretion. The other parathyroids under that situation quiet down. 
FREMONT-SMITH: Atrophy- 
MCLEAN: I do not think you can use the word “atrophy.” They 
subside. The surgeon looks at them and he says, “These other glands 
are atrophied.” They are being studied now with the electron micro- 
scope and more information is coming out about what is going on over 
a long period of time so that integral control may be observed. 
FREMONT-SMITH: You say they quiet down. A sort of functional 
atrophy - an atrophy of function. 
MCLEAN: They function at a lower level. I doubt that they ever 
cease functioning completely. 
RAISZ: There are substantial data from Dr. Sanford I. Roth of 
Massachusetts General Hospital, not only on the functional atrophy of 
the human parathyroid gland but also on the effects of calcium on para- 
Dr. Roth has inferred 
from electron-microscope pictures (we should remember that one can 
only guess at the sequence of events with such static pictures) that 
there are cycles of hormone synthesis and secretion in the parathyroid 
cell. Dr. Roth thinks these cycles are slowed down in high calcium 
and speeded up in a low calcium environment. This kind of effect 
can be seen both in tissue cultures of rat parathyroids and in human 
material. 
COPP: Dr. Talmage, would you like to say something before we 
leave the parathyroids? 
TALMAGE: One particular aspect of parathyroid action has bothered 
me. This aspect was illustrated recently by Harrison and Harrison 
(ref. 48) in a paper relative to vitamin D effects on calcium absorption 
by the gut in vitro. It was not their study of vitamin D that bothered 
me. However, in their discussion they assumed that parathyroid action 
on bone was extremely slow. This assumption was made as if it were 
a generally accepted fact. I think it is very important for us to empha- 
size here that parathyroid is a very rapidly acting hormone. It pro- 
duces effects on bone in minutes, not in hours. We should endeavor 
to counteract the idea of this slow action which is so prevalent in the 
literature. Apparently this idea results from the fact that small calcium 
changes are difficult to identify due to the large pool size of extraosseous 
calcium. 
Unfortunately, Dr. Copp’s recent emphasis that thyrocalcitonin 
is faster acting than parathyroid hormone can add to this misconcep- 
tion. While he is speaking in relative terms, the description of para- 
thyroid hormone in this matter has aided the erroneous concept preva- 
lent in the literature. I believe this is one of the most important 
aspects of the hormone to be kept in mind. 
, thyroid morphology in tissue culture (ref 43). 
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URIST: Does the rate of the response depend on the age of the 
TALMAGE: No. 
COPP: I would like to comment on this, since you brought the 
matter up. I believe parathyroid hormone is fast acting, even in dogs 
and man, but in these species the effect persists for many hours. 
TALMAGE: You are talking about the half-life of the hormone after 
it is secreted. 
COPP: I am not talking about the half-life of the hormone in cir- 
culating blood, which Sherwood et al. (ref. 40) have shown to be on 
the order of 20 to 30 minutes. I am talking of the duration of action, 
which may be for many hours. 
NICHOLS: I think your point is extremely well taken. Part of 
the reason we think it takes so long is because we have always looked 
at it from the point of view of injecting parathyroid hormone into 
intact animals. I think Dr. Arnaud ought to speak about this in rela- 
tion to his newer animal preparations. Our recent experience, using 
thyrocalcitonin, suggests that parathyroid hormone effects occur 
within an hour. 
COPP: We have observed elevations in plasma calcium within 20 to 
30 minutes of intravenous administration of parathyroid hormone in the 
dog, and there must be changes in bone which precede this elevation. 
TALMAGE: Yes; but one-half hour is a relatively short time com- 
pared with 6 hours, as reported by Harrison and Harrison (ref. 48). 
COPP: Well, a 6-hour delay is ridiculous. 
NICHOLS: Good point. Howard Rasmussen suggested in 1961 
(ref. 49) that there are effects of an injection of parathyroid hormone 
that last for a very long time, these being the ones on the bone mineral. 
Recently, we have done some experiments with thyroparathyroidec- 
tomized animals given a single injection of parathyroid hormone, 
looking for the effects on acid production by cells and the solubility 
of the mineral.* It turns out that there is a clear time sequence of these 
events as you would suspect; namely, that an effect on the acid produc- 
tion by the cells can be seen within 1 or 2 hours. This has largely faded 
after 12 to 18 hours: lactate uroduction then falls below normal up to 48 
hours and subsequently drifts back to normal. The mineral effect, 
on the other hand, comes later, lagging anywhere up to 6 to 8 hours 
behind the changes in acid production and this continues to increase 
for as long as 2 days. 
RAISZ: I have contradictory data. In tissue culture one can show 
aniinal? 
*Asher, J. D.; Nichols, G., Jr.; et al.: Unpublished observations. Some of these 
observations were conducted as part of a required class laboratory by members of the 
Harvard Medical School class of 1969. 
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FIGURE 27. Treated versus control ratios 
plotted against time showing the effect of para- 
thyroid hormone (1 pgcglml) on the release of 
calcium and the incorporation of uridine into 
RNA in paired cultures of embryonic bones. 
Each point represents the mean and SE of 8 
to 12 pairs of cultures (6 bones per culture). 
Embryonic bones in which "Ca had previously 
been incorporated were precultured for 24 
hours and then transferred to media with or 
without parathyroid hormone. The relative 
release of 45Ca into the medium and uptake of 
uridine from the medium into the bone RNA 
were measured for various intervals after hor- 
mone addition. [From unpublished observa- 
tions of L. G. Raisz and Ingrid Niemann.] 
an apparently immediate effect on calcium release from embryonic 
bone. These bones are labeled with 45Ca and then precultured so that 
exchangeable 45Ca on the surface is largely removed. During the first 
3 hours after addition of parathyroid hormone, there is a 20-percent 
increase in calcium release (fig. 27). This represents less than 1 
percent of total bone calcium. This release rate continues during the 
first 6 hours; after 6 hours there is a sharp break in the curve and the 
calcium release rapidly increases for parathyroid hormone-treated 
bones. Hence, there is a change from an initial phase of a modest 
parathyroid effect on calcium release to a second phase of augmented 
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parathyroid effect. In these experiments we also studied the effect 
of parathyroid hormone on the incorporation of uridine into bone 
RNA. During the first 6 hours there was inhibition of uridine in- 
corporation. This may represent the known inhibitory effect of 
parathyroid hormone on the osteoblasts. At about 6 hours there is 
an increase in the incorporation of uridine into RNA; this increase is 
even more marked in experiments where the tissue is pulse labeled for 
1 hour (fig. 28). 
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FIGURE 28. 
into RNA after 1-hour pulse label. 
nine pairs of cultures (two to six bones per culture). 
I-hour uridine uptake shows an abrupt increase for the 6- to 7-hour period. 
published observations of L. G. Raisz and Ingrid Niemann.] 
Effect of parathyroid hormone ( 1  &ml) on uridine-5-T incorporation 
Each point represents the mean and SE of six to 
The 
[From un- 
Conditions as for figure 27. 
SAXEN: Is this into the total RNA? 
RAISZ: Yes. This is preliminary work; we have not been able to 
measure pool size or to isolate the RNA and characterize it. It does 
fit in with the idea that parathyroid hormone initially causes a rapid 
effect on calcium movement in the cells and that, subsequently, the 
bone responds with a change in its cell population. We can actually 
see this histologically after 8 to 12 hours in culture with the appearance 
of more osteoclasts. This then goes on to the extensive complete 
resorption that one can see in tissue culture. 
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ROBINSON: Then, is this bone messenger RNA or soluble RNA? 
RAISZ: This is total RNA. We think that the 1-hour incorporation 
is mostly messenger RNA. 
ROBINSON: Why not? Another thing is, if it affected the cell right 
away you would not see the effect for 4 hours, would you? You said 
it takes the cell that long to “tool up.” 
RAISZ: You see messenger RNA synthesis right away. 
COPP: I would like to ask Dr. Belanger to comment on this point, 
since he has some information on the cellular responses in bone to 
injection of parathyroid hormone. There is an immediate effect and a 
delayed effect which might correspond to increased osteoclast activity. 
NICHOLS: Dr. Copp, Dr. Raisz said earlier that he had completely 
opposite data. In point of fact, they are not a bit opposite. The 
early mineral effects that he is seeing occur just when we see an effect 
on cellular acid production, both lactate and citrate. Later on, about 
6 to 8 hours after injection, the passive solubility of the mineral starts 
to change. If I am not mistaken, this is the point where you start to 
get a sharp rise in calcium release. What I am saying is that it takes 
several hours for the surface that we were talking about to become 
modified by the increased cellular acid production which is induced 
by PTH. When you use a live tissue in your system, it is reflected by 
a lag in the calcium release. We get exactly the same thing when using 
our fragments if we keep them alive. 
RAISZ: Having injected the PTE in the animal? 
NICHOLS: Yes. 
RAISZ: You are saying that there is a calcium effect that you could 
not measure, but that you could measure the effect on lactate. 
NICHOLS: Looking at the steady-state distribution of calcium between 
medium and bone, there is an effect in the early phases around live 
pieces of bone. But if you look only at inactivated tissue, the effect 
does not appear until later (ref. 50). The important point is that the 
mineral, and its solubility, is modified by the change that has been 
going on in the metabolism of the cells. 
TALMAGE: I would like to say that we have lots of RNA data not 
only at I hour but at 20 minutes, but I have an entirely different in- 
terpretation on this RNA. I do not believe this early change has 
anything to do with homeostasis. I would just like to say that I have 
these data and would like to discuss them later. 
NICHOLS: Dr. Raisz says it is messenger RNA in its early phase. 
I do not think that is correct. I have reason to believe so, and would 
like to discuss the point later. 
One of the 
important questions is the way in which parathyroid hormone produces 
COPP: You can certainly bring up this matter later. 
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its effect in normal calcium homeostasis. Dr. Belanger has some views 
on this. 
BELANGER: At this stage, I can only offer the following comments 
related to the present discussion. 
If we look at various parts of the skeleton after endogenous stimula- 
tion of the parathyroid gland, or after parathyroid hormone, as done by 
Dr. Copp, we can see this. If we compare one particular region, for 
instance, in these two fashions, first look at it in its mineralized phase 
through a modified type of microradiography using alpha bombardment, 
we can see that the loss in density is coincidental in the various areas 
of bone. 
On the other hand, the loss of organic material is over a wider area 
than the loss of mineral substance (ref. 51). These data, which we 
obtained in British Columbia, allowed us to think that the primary 
effect of parathyroid hormone was on the cells and that the immediate 
response of the cell was to destroy somehow or to modify the organic 
substance around some of these cells; the amount of destruction being 
far greater than the amount of loss of salt seemed to indicate that the 
organic effect was primary. 
COPP: The osteocyte is now threatening the osteoclast. 
BELANGER: These are two different things, two different worlds 
COPP: Is there any further comment on the parathyroid? 
URIST: Dr. Arnaud, your work has been mentioned several times. 
Do you agree with what has been said about it here? 
ARNAUD: I am afraid that both the mechanism of PTH action and 
bone cell metabolism are exceedingly complex and the techniques 
available for their study in vivo are quite crude. The measurement 
of an increase in the concentration of calcium in the plasma of the 
PTH-treated parathyroidectomized organism, although a physiologically 
important effect, merely represents the end result of a series of reac- 
tions of which we know little. Recognizing this, the measurement 
of the time required to observe this result has been complicated by 
the fact that most studies have been done in animals whose thyroid 
glands have been left intact. Under these conditions, thyrocalcitonin 
secretion is not controlled and its presence might be expected to 
inhibit the plasma-calcium response to administered PTH. This is 
in fact the case. When the thyroparathyroidectomized rat is given 
parathyroid hormone a response can be observed as early as 30 minutes 
and possibly sooner. I should expect that if one could measure 
another specific, and more sensitive, index of parathyroid hormone 
action on bone, an almost instantaneous effect could be observed. 
Do you consider half an 
hour fast or slow? 
indeed. 
COPP: I would like to ask one question. 
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ARNAUD: I do not think that we have the techniques to measure 
COPP: It has been known for a long time that a response may occur 
ARNAUD: Well, we are measuring the end result. 
BAUER: Does the parathyroid hormone act in the absence of vita- 
min D? 
ARNAUD: We have made our position rather clear about this. Our 
studies have shown, first, that it is extremely difficult to produce an 
animal which is entirely depleted of vitamin D ;  and second, that the 
osseous response, if any, of this animal to parathyroid hormone depends 
upon the degree of vitamin D deficiency induced (refs. 52 to 54). 
Harrison et al. (ref. 55)  and Harrison and Harrison (ref. 56) were the 
first to demonstrate this dependency relationship. There has been 
work reported which is contradictory (refs. 57 and 5 8 ) ,  but the major 
portion of it can be questioned on the basis of the adequacy of vitamin 
D depletion. 
The important concept that has come out of our studies of vitamin D 
deficiency and its interrelationship with parathyroid hormone action 
is that parathyroid hormone appears to have its characteristic effect 
on the renal tubule in the iritamin-D-deficient animal, whereas it does 
not have its characteristic effect, or at least the degree of effect, on bone. 
This is interesting in that studies done by Rasmussen et al. (ref. 59) 
and by Tashjian et al. (ref. 60) with inhibitors of protein synthesis seem 
to be analogous to the results observed in vitamin D deficiency. The 
influence of parathyroid hormone on the kidney of the actinomycin-D- 
treated and the vitamin-D-deficient rat is qualitatively the same as that 
of the normal animal, whereas its effect on bone is, in large part, blocked. 
Actino- 
mycin D does not specifically block parathyroid action in bone, at 
least relative to the control of plasma-calcium levels. It is true that 
this drug drops calcium levels and appears to inhibit the action of in- 
jected hormone, but this is a result of the general effect of this drug on 
all cells. We feel that we have demonstrated convincingly that the 
hormone is still functioning in animals under heavy actinomycin D 
treatment. 
COPP: If we can continue this discussion later, I would now like 
to complete the endocrine contribution to calcium homeostasis. 
We will now turn our attention to the thyroid, the other endocrine 
gland directly involved in calcium homeostasis. In our original 
experiments (ref. 6 1 )  in which we perfused the thyroid-parathyroid 
apparatus in the dog with high and low calcium blood, we observed 
that exposure of the glands to hypercalcemia resulted in a prompt fall 
in systemic plasma calcium which was much more rapid than the fall 
how rapidly parathyroid hormone acts. 
within 20 to 30 minutes. 
TALMAGE: I would like to disagree with that for the record. 
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FIGURE 29. Changes in plasma calcium during successive perfusions of the thyroid- 
parathyroid glands in a fasting dog with blood alternately high and low in calcium. The 
glands were removed as indicated by the arrow at the end of the last EDTA infusion. 
[Adapted from ref. 42; reprinted by permission of the publisher.] 
which occurred after surgical removal of the glands. In the definitive 
experiment illustrated in figure 29, high calcium perfusions of the 
‘glands caused a rapid fall in blood calcium, while low calcium (EDTA) 
perfusions caused a rise, presumably due to the release of endogenous 
parathyroid hormone (ref. 62). To test the current hypothesis that the 
effect of hypercalcemia was due to suppression of parathyroid hormone 
production, after establishing the responses through two cycles, we 
removed the thyroid and parathyroid glands. Instead of the antici- 
. pated fall, the plasma calcium rose and remained elevated for many 
hours. It was evident that the effect of hypercalcemia was a result 
of the release of a humoral agent which was responsible for the rapid 
fall in systemic blood calcium. Indeed, we found that the high calcium 
perfusates did produce hypocalcemia when injected into a second dog. 
These results were confirmed by Kumar et al. (ref. 63), by using ion- 
exchange resins to modify the calcium concentration in the perfusing 
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blood. We named this new hormone 
to be involved in regulating the leve 
fluids. While first thought to come from 
apparent that the calcitonin originally demonstrated in these experi- 
ments was of thyroid origin (ref. 64). 
observed that destruction of the parathyroids by hot-wire cautery 
caused a much greater fall in plasma calcium than that which occurred 
after surgical removal of the glands. They were also able to extract 
a potent hypocalcemic and hypophosphatemic substance from thyroid 
tissue, to which they gave the name “thyrocalcitonin” to indicate 
the gland of origin, and its possible identity with calcitonin. Care 
(ref. 66) has clearly demonstrated release of thyrocalcitonin by high 
calcium perfusion of pig thyroid, which contains no parathyroid tissue. 
(See fig. 30.) In collaboration with Dr. Belanger, we have also shown 
that 24 hours of mild hypercalcemia (+ I O  to 15 mg/ 100 ml) in the  sheep 
results in hypertrophy of thyroid cells - particularly the parafollicular 
light cells. 
NICHOLS: May I ask if those changes were in both the parafollicular 
and the follicular cells? 
In 1963, Hirsch et al. (ref. 
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FIGURE 30. Changes in systemic plasma cium associated with high 
fusion of the pig thyroid in situ. The calcium concentration in the perfu 
indicated. [From data in ref. 66; reprinted by permission of the author.] 
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COPP: Dr. Belanger should comment on this point. All thyroid 
cells appeared larger, but the effect was most marked in the parafol- 
licular cells. Dr. W. Chase prepared electron micrographs which 
showed increased activity in the endoplasmic reticulum of these cells. 
BELANGER: Of course, these are old names which date back to the 
1920’s. It is now possible to demonstrate that these are two aspects 
of the same cell, and that the parafollicular cells, which are not para- 
follicular at all, are away from the follicle and are distal to the colloid. 
These are young cells that are possibly capable of responding to 
STH-stimulation but not to TSH, and are capable of manufacturing 
thyrocalcitonin but not thyroid hormone as we understand it. 
Now, as these cells mature and move toward the colloid to replace 
the cells that are dying out there, they also acquire the ability to manu- 
facture thyroid hormone. Therefore, in our estimation, all types of 
cells can make thyrocalcitonin, but only the more adult, or more mature, 
cells can make thyroid hormone. 
PECK: Did you find any evidence for increased thyroxine genesis? 
COPP: With calcium? 
PECK: Yes. 
COPP: No. That would be an interesting experiment but we 
have not done it yet. 
BELANGER: There is histochemical evidence to the effect that 
the production of thyroid proteolytic enzyme, which is associated 
with the utilization of thyroglobulin, actually is stimulated by treat- 
ment such as Dr. Copp has described; that evidence would indicate 
that both functions are enhanced. 
COPP: Both Dr. Belanger and we have observed some thyroid 
hyperplasia in rats made hypercalcemic by feeding a high ciilcium, low 
phosphate diet. However, the effects were not as striking as in the 
sheep. 
NICHOLS: Do you think the calcitonin is stored with the colloid, 
or is this very rapid change a secretory phenomenon? 
HEANEY: Apparently there is a vast difference in the amount of 
colloid. It seems inconceivable to me that an equivalent amount of 
thyroid hormone could have been secreted under the conditions that 
would not have affected- 
BELANGER: 1 do not know about the physiologic detection, but 
certainly since the proteolytic enzyme production is also increased, 
it seems that as the utilization of this thyroid hormone is increased, 
then the residual amount of colloid could very well not be representative 
of the amount of production of the hormone, because the turnover 
rate also appears to be considerably greater. 
It would be very 
interesting to see the effect on protein-bound iodine (PBI). 
COPP: We should do this experiment sometime. 
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4. Remove ether, vacuum 
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FIGURE 3 1.  
fresh, frozen, porcine thyroid glands. 
(TCA) powder. 
Flow diagram of the extraction of thyrocalcitonin from dried, defatted, 
Final product is a crude trichloroacetic acid 
1. Dissolve in  20% acetic acid 
0.01 M cysteine 
2. N a C I  precipitation 
resulting in a crude powder extract. This procedure 
with that applied to 
procedure for parathyroid hormone (ref. 70). This crude powder 
extract is relatively stable when refrigerated in the lyophilized state 
at 4" C and produces a decrease in the plasma calcium of calcium- 
deficient rats of 1.5 mg1100 ml at an intravenous dose of 30 to 40 
micrograms of protein (ref. 71) 1.5 hours after administration. This 
crude powder is further purified by dextran gel chromatography on 
columns of Sephadex G-75 using 0.2 M ammonium acetate, pH 4.6 
as eluant. The eluted material is pooled and lyophilized, as shown 
in figure 32. Although considerable biologic activity is observed in 
both pools, tubes 92 to 100 and tubes 100 to 120, the greatest was 
present in the former, and it was chosen for further characterization. 
When this material is subjected to either starch gel (fig. 33) or poly- 
acrylamide (fig. 34) electrophoresis, it migrates as a single component. 
1.41 
FIGURE 32. Gel filtration of crude thyroid 
t (see fig. 3 1) on Sephadex G-75 column 
es 130 centimeters. Th 
0.2 M ammonium acetate, pH 4. 
in tubes 92 to 102 contained the major portion 
of the biologic activity. [From tenenhouse 
et al., ref. 68.1 
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~ U R E  33. The patterns obtained on starch gel electrophoresis when crude and 
purified preparations of thyrocalcitonin were analyzed. Crude TCA powder (left), 
active fraction from gel filtration on G-100 (middle), and active fraction from gel 
filtration on Sephadex G-75 (right). The material on the right is the substance which 
was further characterized. [From Tenenhouse et al., ref. 68.1 
It has a molecular weight of approximately 9000, and amino acid 
analyses (table I) show that it is unique in that it has a single, half- 
cystine residue. 
HEANEY: Dr. Arnaud, in virtue of our past discussions, are there 
any iodinated amino acids in that molecule? 
ARNAUD: I will tell you about an interesting finding. The -SH 
group of the cystine residue is not titrable, so that it is not free, at 
least not by any criteria that we have been able to determine. It is 
possible that an iodine molecule might be linked with this -SH group; 
we have not been able to look into this yet. But, it is important to 
remember one thing id this regard. The hormone-extraction procedure 
involves the addition of cysteine at two separate points; it is possible 
that the molecule might bind this amino acid so that the final product 
contains a cysteine residue in nonpeptide linkage. 
We have been able to produce antibodies to this purified material 
by conjugating it with carbodiimide (ref. 72) to rabbit albumin and by 
injecting the conjugated material into rabbits with Freund’s complete 
adjuvant. Figure 35 is a gel diffusion pattern in which we have placed 
the antibody in the center well (IV), a homogenate of porcine thyroid 
tissue in well 111, the crude TCA extract in well I ,  and the purified 
material in well 11. Therefore, the antibody is quite specific for the 
isolated peptide in that lines of identity are present. 
Figure 36 is a microimmunoelectrophoretic study of the crude TCA 
I extract (I) and purified preparation (11) with antibody in the longi- 
tudinal center well (IV). There is a single band of precipitation where 
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FIGURE 34. Pattern obtained on polyacrylam- 
ide disk electrophoresis of the active fraction 
from gel filtration on Sephadex G-75. Sam- 
ple size was 100 micrograms. 
antibody and antigen have reacted, which again supports the idea that 
the prepared antibody is specific for the isolated polypeptide. 
We decided that we would like to find out which cells of the thyroid 
gland produce this polypeptide. With Gary Hargis and Gerald Wil- 
liams in Chicago, we carried out a series of immunofluorescent studies 
of the thyroid gland with the antibody conjugated to the fluorescent 
material, lissamine rhodamine B 200 (ref. 73). We see (fig. 37) fluo- 
rescence over the cytoplasmic material of all the thyroid cells of the 
pig. The thyroid glands of the dog, rat, and human have been studied 
in a similar manner with similar results. Notice that there is no specific 
fluorescence over any of the colloid. 
PECK: Can you block that fluorescence? 
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TABLE I 
AMINO ACID COMPOSITION OF THYROCALCITONIN 
Residues per molecule 
Amino acid 
22 hours 
~ 
Cysteic acid ................................. 
NH.3.. ......................................... 
Tryptophan.. ................................. 
- 
7.06 
3.69 
3.76 
9.72 
4.36 
5.22 
7.82 
4.24 
.50 
.90 
2.79 
9.15 
2.22 
2.13 
8.03 
8.38 
1.22 
3.60 
1.00 
72 hours 
- 
6.86 
3.26 
3.00 
9.25 
4.86 
5.06 
4.20 
.67 
2.76 
8.96 
2.00 
2.20 
10.16 
8.29 
1.27 
3.48 
7.83 
- 
............ 
22 hours 
oxidized 
1.07 
3.95 
3.48 
- 
- 
- 
5.42 
7.95 
4.25 
- 
- 
2.84 
9.27 
1.99 
8.08 
1.02 
3.62 
- 
- 
- 
Calculated 
1 
7 
4 
4 
10 
4 
5 
8 
4 
1 
3 
9 
2 
2 
7 
8 
1 
4 
1 
.50 
ARNAUD: Yes. It is specifically blocked in two different ways. If 
we overlay the tissue with nonfluorescinated antibody, fluorescence is 
totally blocked. Similarly, incubation of the fluorescinated antibody 
with the isolated polypeptide overnight at 4" C before overlaying the 
tissue results in the complete absence of fluorescence. 
We became intrigued with the idea that parathyroid hormone and 
thyrocalcitonin might be chemically similar because of their similar 
molecular weights. If one lines up the two molecules in terms of their 
amino acid residues (table II), they compare rather closely. There 
are some important differences, however. Of particular note is the 
presence of three histidine residues in parathyroid hormone, compared 
with only one in the thyrocalcitonin peptide, and the absence of cysteine 
in parathyroid hormone. Further, when one elutes these polypeptides 
from carboxymethyl cellulose (CMC) columns with identical concen- 
tration gradients of ammonium acetate (fig. 38), parathyroid hormone 
comes off at a concentration of 0.33 M and the thyrocalcitonin pep- 
tide at 0.1 M, indicating that parathyroid hormone is a more highly 
charged molecule. 
31 1-496 0-68-6 
72 Biology of Hard Tissue 
FIGURE 35. Microimmunodiffusion pattern of reaction between antiserum to 
TCT and three preparations of TCT, showing pattern of fusion. I ,  crude porcine 
TCT extract; 11, active fraction from (3-75 fractionation; I l l ,  homogenate of 
porcine thyroid tissue; IV, rabbit antiserum to material in 11. [From Hargis et al., 
ref. 73; reprinted by permission of the publisher.] 
FIGURE 36. Microimmunoelectrophoresis pattern of reaction between antiserum 
to TCT and two preparations of TCT, showing single corresponding arcs in 
anodic position (barbital buffer, pH 8.8). I ,  crude TCA extract; 11, active frac- 
tion from fractionation on G-75; IV, rabbit antiserum to 11. [From Hargis et ai., 
ref. 73; reprinted by permission of the publisher.] 
Dr. Littledike, Miss Tsao, and I have developed a radioimmunologic 
procedure for the assay of this polypeptide in biologic fluids, which 
is similar to that described by Yalow and Berson (ref. 74) for insulin. 
The radioimmunoassay depends on the competitive inhibition of 
stable thyrocalcitonin with 1311-labeled thyrocalcitonin for antibody 
binding, and the degree to which stable thyrocalcitonin will inhibit 
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Leucine. ............................................... 
Tyrosine.. .............................................. 
Phenylalanine.. ...................................... 
NH3 ..................................................... 
FIGURE 37. 
showing fluorescence confined to thyroid epithelial cells. 400 X. 
et al., ref. 73; reprinted by permission of the publisher.] 
Porcine thyroid gland: fluorescent antibody globulin to TCT stain, 
[From Hargis 
9 
2 
2 
7 
TABLE 11 
COMPARISON OF THYROCALCITONIN AND PARATHYROID HORMONE IN AMINO ACID 
COMPOSITION 
Histidine.. ............................................. 
Tryptophan.. .......................................... 
Thyrocalcitonin Parathyroid hormone I I 
8 7 
1 3 
4 4 
1 1 
Threonine.. ........................................... 
Glutamic acid.. ...................................... 
Glycine.. ............................................... 
Valine.. .......... 
Cystine ................................................. 
Isoleucine.. ........................................... 
......................... 
7 
4 
4 
10 
4 
5 
8 
4 
1 
3 
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FIGURE 38. Column chromatography of por- 
cine TCT polypeptide and purified parathyroid 
hormone (PTH) on carboxymethyl cellulose 
using increasing ionic strength gradient, am- 
monium acetate, pH 5.0. Major protein peak 
of PTH elutes at 0.33 M and that of TCT at 
0.1 M .  
iodinated thyrocalcitonin from being bound to antibodies is propor- 
tional to the concentration of stable thyrocalcitonin added to the 
mixtures. 
Antibody-bound 1311-labeled peptide is separated from free l3'I-1a- 
beled peptide by a chromatoelectrophoretic technique on Whatman 
3 MC filter paper strips and subsequently evaluated by means of a 
chromatogram strip counter and peak area integration. Figure 39 
shows a series of tracings obtained when progressively increasing 
quantities of stable peptide are added to mixtures containing the same 
amount of antiserum ( 1  to 50 000 dilution) and labeled peptide after 
4 days' incubation at 4" C .  As you can see, increasing the concen- 
tration of stable peptide is associated with a decrease in the quantity 
of labeled peptide bound to antibody. 
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FIGURE 39. Scans of radioactivity on paper-strip chromatoelectrophoretograms of mix- 
tures of ‘31’I-labeled porcine thyrocalcitonin (TCT) and rabbit antiporcine TCT antiserum 
(dilution 1 to 50000) in the same concentration but with varying concentrations of un- 
labeled porcine TCT as indicated. The right of the two peaks on each tracing represents 
migrating antibody bound, and the one on the left, free ‘31I-labeled peptide which remains 
at the origin. The tracing marked ‘‘1311 TCT” is a scan of a mixture to which no antiserum 
had been added and the small migrating peak “damaged” 13l l  TCT. No unlabeled-TCT 
was added to the mixture represented by the tracing marked ‘‘131I TCT+AB.” The 
standard curve (right) was obtained by measuring the areas under the bound and free 
peaks of each scan, expressing them as ratios (B/F) and plotting this value against the 
logs of the corresponding known concentrations of added, unlabeled TCT. The scan 
just above the standard curve was obtained when the peripheral plasma of a calcium 
loaded intact young pig was substituted in a dilution of 1 to 40 for unlabeled TCT in 
the mixture. Its concentration was calculated as 500 mpg/ml of whole plasma. 
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If one plots the ratios of the areas under these curves (the ratio of 
the antibody bound to free labeled peptide) against the log of the con- 
centration of added stable peptide, one obtains a straight line. To 
measure the concentration of peptide in an unknown solution, one 
merely adds an aliquot to the mixture of antibody and labeled peptide 
in place of the standard stable peptide. The assay can easily detect 
1.0 mpg of peptide per milliliter of incubation mixture. Greater 
sensitivity can be achieved but it is not necessary because the concen- 
trations in normal plasma are high (young pig, 100 to 400 mpg/ml). 
In nine consecutive assays, the index of precision (A) w i s  0.079. 
If too much is added, the 
competition between labeled and stable peptide for antibody binding 
becomes difficult to demonstrate, and the sensitivity of the assay 
suffers. 
Using this radioimmunoassay as a sensitive tool, we sought to 
determine if there was any immunologic similarity between highly 
purified bovine parathyroid hormone and the thyrocalcitonin molecule. 
To our surprise, minimal crossreactivity could be demonstrated.' 
Our attempts at radioimmunoassay in the beginning were quite 
crude, and my attempts during the past 6 months have been primarily 
to improve the selection of antisera and to look at thyrocalcitonin from 
other species. 
Since my background is internal medicine, I was interested to see 
if a polypeptide similar to the one we isolated from porcine thyroid 
glands was present in human plasma. Figure 40 is from a study made 
using serial dilutions of my plasma in the immunoassay system. The 
value for the bound-to-free ratio obtained with my undiluted plasma 
falls directly on the curve obtained with standard porcine peptide; with 
serial dilution, an almost identical set of points is observed. This 
indicates that an immunologically similar polypeptide circulates in 
human plasma, and it can be precisely measured in terms of porcine 
peptide equivalents. 
We have not really gone very far in measuring the hormone in disease 
states. All we can say is that it circulates in substantial quantities. 
We have obtained from 25 normal sera, or relatively normal sera, an 
average of 30 to 50 mpg/ml. This is on the order of 50 times the level 
of parathyroid hormone which circulates in bovine plasma (ref. 40). 
URIST: Have you seen a patient with idiopathic hypoparathyroidism? 
ARNAUD: I have measured the polypeptide in the plasma of these 
individuals, and I do not think it is increased; but I would not Iike to 
go on record. 
The concentration of antibody is critical. 
1 Exhaustive studies now indicate that the presence of crossreactivity was a result of 
glassware contamination. 
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FIGURE 40. Plot of the ratio of antibody bound to free I 3 l I  porcine TCT 
peptide against the concentration of added stable porcine TCT peptide 
(X-X) and human plasma in various dilutions (o----<>). Similarity 
of curves indicates that a substance which circulates in human plasma is 
immunologically similar to the added porcine TCT peptide. 
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TC-J .......................................................... 
Control.. ........................ ............. 
WALSER: Have you done a thyroidectomized subject? 
ARNAUD: Only thyroidectomized pigs. It is much lower, but quite 
consistently present in all of the animals thus far studied. It is pos- 
sible that this is due to ancillary thyroid tissue, but this finding con- 
cerns us very much and has led us to consider alternative possibilities, 
such as, that the polypeptide that we isolated may be produced by 
tissues other than the thyroid gland or that there may be a carrier of 
the hormone (thyrocalcitonin). 
COPP: Have you measured this in osteoporotic patients? 
ARNAUD: No; we have not. I have been able to measure thyro- 
calcitonin in human plasma for 4 weeks now. 
NICHOLS: I would like to know where thyrocalcitonin works in the 
bone. 
RAISZ: According to figure 22, thyrocalcitonin acts to inhibit bone 
resorption. There is some preliminary evidence that this is the way 
thyrocalcitonin works in vivo. I think Dr. Talmage has evidence on 
this point. The evidence for inhibition of bone resorption in tissue 
culture is fairly clear. We measure the release of 4sCa from prelabeled 
bone in tissue culture into a medium which contains a large amount of 
stable calcium, so that major changes in this release can be achieved 
only by affecting resorption. Changes in deposition of calcium would 
take calcium largely from the unlabeled pool and very little 45Ca would 
be returned to the bone. Our experiments (ref. 75) show that in tissue 
cultures with and without parathyroid hormone, the release of radio- 
calcium is largely inhibited by the action of thyrocalcitonin (table 111). 
TABLE 111 
FFFECTS OF A CRUDE THYROCALCITONIN PREPARATION (TC-J) AND PARATHYROID 
HORMONE (PTH) ON 45Ca RELEASE FROM EMBRYONIC B O N E S ~  
Dose 
3 pg/ml 10 pg/ml 30 pglml 
910 700 770 
920 920 1050 
Difference.. ................................................. 10 f 64 
TC-J+ PTH ................................................ 1510 
.................. 1880 
Difference.. ................................................. 370 f 180 
a 220 4 55 a 280 f 80 
780 890 
1580 1750 
a 800 2 60 a 860 f 180 
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Since this experiment was done we have more refined materials, and 
a partially purified rat thyrocalcitonin has been prepared which is 
effective in doses of as little as 0.1 pg/ml. When parathyroid hormone 
is added to the culture, calcium release is increased in bones that are 
not treated with thyrocalcitonin; but the entire parathyroid effect is 
brought back to nonresorbing levels by thyrocalcitonin. In addition, 
thyrocalcitonin inhibits bone resorption in the absence of parathyroid 
hormone; Le., what we call control bone-resorption. 
BELANGER: There are some other experimelits that have a bearing 
on this matter. These are the experiments, done immediately before 
this conference, in which we have evidence that the thyroid gland has 
been stimulated into taking up the kind of aspect that Dr. Copp has 
shown. We did this in rats, and then looked at the bones and observed 
a thyrocalcitonin effect; but it is some sort of an effect that is inhibitory 
under, let us say, thyrocalcitonin production-like conditions. 
There are areas of the bone where the cells become enlarged and 
are actually surrounded by areas of matrix in which the staining prop- 
erties will change; for example, under these conditions the usual color 
with the use of Wright's stain will change to an azure staining. 
Now, by comparing this type of staining with a known stain for meta- 
chromasia, such as methylene blue, the same areas in the vicinity of 
the large cell show some metachromasia. This is generally considered 
as indicative of the presence of some mucopolysaccharides. 
In the tibias from rats on a diet low in phosphate, we observed a 
complete disappearance of these zones of metachromasia except where 
there was a remnant of cartilage. There are no more of these hyper- 
trophic osteocytes; the osteocytes now appear to be small, and some 
of them have even died. If  you look in other areas more reactive than 
the tibia, such as the alveolar bone between the molars, we can see 
that some of these cells, after 7 days of this type of treatment, become 
totally degenerated. I suggest at this point that if this is indicative of 
a thyrocalcitonin effect, then the thyrocalcitonin effect is manifested 
by an inhibition of the metabolism of the large osteocytes which preside 
over osteolysis. 
URIST: What is the target of thyrocalcitonin? Dr. Belanger, do 
you suggest that calcitonin controls the process of osteolysis? 
BELANGER: No, not quite. Osteolysis is the end product, but I 
think there is some sort of change in the metabolism of the osteocyte 
whereby it cannot perform its normal osteolytic role- particularly in 
the large, mature osteocyte which is actually responsible for osteolysis. 
The osteolytic role may be due to the production of some acids, as 
Dr. Nichols has mentioned, or perhaps due to the production of some 
enzymes that break down the organic matrix of the bone. These 
' 
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effects, then, do not take place, and the cells appear either to remain 
small or become small. I do not know at the moment. 
URIST: Is the osteocyte a target? 
BELANGER: Yes. This is what these experiments seem to indicate. 
URIST: Do you agree with Dr. Raisz, that the osteoclastic activity 
is inhibited by thyrocalcitonin? 
TALMAGE: He did not say. I do not 
think that we know which cell is responsible. 
RAISZ: I only said bone resorption. The response that I showed 
earlier to parathyroid hormone in the first 3 hours, during which no 
cellular changes can be seen, is also inhibited by thyrocalcitonin. 
He  just said bone resorption. 
BELANGER: Osteoclasts are nowhere around. 
TALMAGE: I think it is important to emphasize that thyrocalcitonin 
is just as active in parathyroidectomized animals as it is in control 
animals. In our experimental system, we place the animal under a 
calcium stress by our peritoneal lavage system. By this method 
calcium is removed from the animal at a maximum rate; in the animals 
maintained on a calcium-free diet, this calcium must be supplied by 
bone. By such a system, we are magnifying the progress of bone 
resorption and minimizing bone accretion. If the animals are given 
thyrocalcitonin during this process, the rate of calcium removal is 
diminished equally in both control and parathyroidectomized animals. 
The only difference is the length of time in which the effect lasts. In 
the animal with intact parathyroids, it reaches its peak effect in 1 hour 
and returns to normal in 2 or 3 hours. Without parathyroids, it reaches) 
its peak in 2 or 3 hours and-may not return to normal for 5 or 6 hours. 
The point should be made that phosphate drops proportionately 
with calcium. Another interesting point pertains to the removal of 
radioisotopes of calcium and phosphate administered 18 hours or 3 
weeks prior to treatment. Thyrocalcitonin caused a reduction in the 
removal rate during peritoneal lavage with a calcium-free rinse. This 
reduction was seen in all animals. In parathyroidectomized animals, 
only long-term administered radioactivity is affected. Because of 
this difference we do not feel that the two hormones, while producing 
opposite effects, necessarily work at the same loci in bone cells. 
COPP: I might point out that both Dr. Munson and Dr. Wase have 
some indirect evidence that thyrocalcitonin may also enhance the 
deposition of calcium in bone. 
BELANGER: That is secondary. 
PRITCHARD: I must comment for a moment on the histologic problem 
of interpreting osteocyte behavior. It seems very odd that the osteo- 
cytes farthest from the blood vessels should be the ones to react. I 
am not happy about the interpretation given. I think the explanation 
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is that the osteocytes of primary woven bone are different from the 
osteocytes of secondary lamellar bone. 
COPP: I would like Dr. Arnaud to show his experiment demonstrat- 
ing the control of thyrocalcitonin secretion. 
ARNAUD: This is an experiment done in a female pig weighing 55 
kilograms (fig. 41). We measured plasma calcium, phosphate, and 
immunoassayable thyrocalcitonin peptide before and after calcium 
loading, when the animal was intact and after its thyroid gland had 
been surgically excised. The maximum for thyrocalcitonin is about 
160 mpglml. 
This study was made at a time when the radioimmunoassay was 
relatively insensitive and normal plasma levels could not be measured. 
When a calcium load was given to the animal when its thyroid was 
intact, a modest degree of hypercalcemia was observed. Coincident 
with the hypercalcemia, there was a precipitous rise in the level of 
PLASMA CALCIUM o--O 
PLASMA PHOSPHATE H 55 Kq 
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FIGURE 41. Effect of intravenous calcium loading on the concentration of 
calcium, phosphate, and thyrocalcitonin (TCT) in the arterial plasma of a pig 
before and after thyroidectomy. TCT levels below 60 mpg not measurable at 
this time in the development of the radioimmunoassay. (Multiply scale for 
TCT times 10.) 
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thyrocalcitonin in the plasma. After the calcium loading was discon- 
tinued, you can see that there is a relatively rapid return of the plasma 
calcium to control, perhaps to below control levels, and an immediate 
decrease in the concentration of thyrocalcitonin to nonmeasurable 
levels. This occurred over a period of 20 minutes or so: it is a rough 
estimate of the rate of disappearance of' endogenously secreted 
polypeptide. 
In contrast, a markedly different calcium curve is observed when a 
calcium load is given to the same animal after thyroidectomy. The 
degree of hypercalcemia that develops is two to three times greater 
than when the thyroid gland is present, while the level of thyrocalcitonin 
remains undetectable. 
COPP: I would like to thank all of the participants in this session. 
